Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1050.Time spend outdoors in summer,50404,0.0654506438778223,0.0293828688881668,0.00786022085701542,0.123041066898629,0.0259233522390193
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1060.Time spent outdoors in winter,48198,-0.0408656838061066,0.0325095806699965,-0.1045844619193,0.0228530943070866,0.208755909340003
CD300E,CMRF35-like molecule 2,Physical activities,X1070.Time spent watching television (TV),51226,0.265614131988823,0.0292236267444102,0.208335823569779,0.322892440407867,1.07938721044771e-19
CD300E,CMRF35-like molecule 2,Physical activities,X1080.Time spent using computer,48238,-0.0830181223089338,0.0286932311607305,-0.139256855383966,-0.0267793892339019,0.00381636247612154
CD300E,CMRF35-like molecule 2,Physical activities,X1090.Time spent driving,45488,-0.140177304673726,0.0314456970938327,-0.201810870977638,-0.078543738369814,8.3354695001826e-06
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1160.Sleep duration,52302,0.0625091674584832,0.0264749936732604,0.0106181798588927,0.114400155058074,0.0182306079024111
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,36077,0.00562905932623829,0.0162380449021118,-0.0261975086819009,0.0374556273343775,0.728857505872472
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,36077,-0.00440109491776882,0.0179682232745906,-0.0396188125359665,0.0308166227004288,0.806511407588847
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,36077,-0.0189132563798641,0.0189394608714502,-0.0560345996879065,0.0182080869281783,0.31801286484057
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,36077,0.00365276449153339,0.0194955981112295,-0.0345586078064765,0.0418641367895432,0.851380682405987
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,36077,0.0283462677038428,0.0199302608535957,-0.0107170435692049,0.0674095789768905,0.154988788868527
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,36077,-0.0412690971329542,0.053112954739887,-0.145370488423133,0.0628322941572243,0.437179671161127
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,36077,0.0975976994285702,0.0628956065651239,-0.0256776894390727,0.220873088296213,0.120766501099451
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,36077,0.0431757712764492,0.0317689067873011,-0.0190912860266609,0.105442828579559,0.174169357554728
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,36077,-0.00113860126033463,0.0243354553649738,-0.0488360937756834,0.0465588912550141,0.962683640052191
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,36077,0.00701493691026394,0.0164147314968176,-0.0251579368234985,0.0391878106440264,0.669132227066269
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,36077,0.0415528886497454,0.0258564602033994,-0.00912577334891743,0.0922315506484083,0.108083383091192
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,36077,-0.00637577746083276,0.0122343571592736,-0.030355117493009,0.0176035625713435,0.602286698569296
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,36077,-0.0198092311897075,0.0167404935801308,-0.0526205986067639,0.0130021362273488,0.236723039375788
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,36077,0.0275880912777775,0.0264406838780505,-0.0242356491232015,0.0794118316787564,0.296798877520987
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,36077,0.0120705805867111,0.0245550402825714,-0.0360572983671289,0.060198459540551,0.623036073856848
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,36077,0.0633348767584434,0.0299902331398599,0.0045540198043179,0.122115733712569,0.0347323906140078
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,36077,0.0417282459785728,0.0294201721242647,-0.015935291384986,0.0993917833421316,0.156128846144261
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,36077,-0.00563889482562869,0.0187084518372273,-0.0423074604265942,0.0310296707753368,0.76311105211144
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,36077,0.0165041905150659,0.0182898974497061,-0.0193440084863581,0.0523523895164898,0.366891284798869
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,36077,-0.0293094983915179,0.0202550835859823,-0.0690094622200432,0.0103904654370074,0.147933418827514
CD300E,CMRF35-like molecule 2,Health and medical history,X120040.Fatigue severity over the past week,36083,0.2435393306393,0.0519033892061043,0.141808687795336,0.345269973483265,2.75130417300115e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,36086,0.183720939120176,0.0513320910774887,0.0831100406082982,0.284331837632054,0.000347007172225817
CD300E,CMRF35-like molecule 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,36086,0.0295458763679726,0.0564105291302781,-0.0810187607273725,0.140110513463318,0.600457316737849
CD300E,CMRF35-like molecule 2,Health and medical history,X120098.Mobility problems today,36088,0.323055243292567,0.0596058311882069,0.206227814163681,0.439882672421453,6.15039594343432e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X120099.Self-care problems today,36088,0.200535157177317,0.0890715495607683,0.0259549200382109,0.375115394316423,0.0243894733630171
CD300E,CMRF35-like molecule 2,Health and medical history,X120100.Problems doing usual activities,36088,0.155432986065366,0.0577781865367481,0.0421877404533399,0.268678231677392,0.00715746870952512
CD300E,CMRF35-like molecule 2,Health and medical history,X120101.Pain or discomfort today,36088,0.0313347801175362,0.0515804454108901,-0.0697628928878084,0.132432453122881,0.543541950795079
CD300E,CMRF35-like molecule 2,Health and medical history,X120102.Anxiety or depression today,36088,0.173377431057346,0.0651654388993001,0.0456531708147174,0.301101691299974,0.00781741082151225
CD300E,CMRF35-like molecule 2,Health and medical history,X120103.Scale to indicate how health is today,36070,-0.0218936741842038,0.00532085774198616,-0.0323225553584967,-0.011464793009911,3.91868076457914e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,36072,0.216941482855462,0.0643089908176491,0.0908958608528699,0.342987104858054,0.000746170596313953
CD300E,CMRF35-like molecule 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",36070,0.17700249361437,0.0682227905798572,0.0432858240778502,0.31071916315089,0.00949199467422712
CD300E,CMRF35-like molecule 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",36076,0.0967844888098846,0.0522189145725529,-0.00556458375231912,0.199133561372088,0.0638590725675432
CD300E,CMRF35-like molecule 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,36081,0.217484713796464,0.0532695746348629,0.113076347512132,0.321893080080795,4.49755363465273e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,36080,0.335205181110762,0.0748023422291185,0.18859259034169,0.481817771879834,7.53249196910278e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,36063,0.0842360907076474,0.0721737907591923,-0.0572245391803695,0.225696720595664,0.243195765323251
CD300E,CMRF35-like molecule 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,36083,0.0979388068195251,0.0688900286418356,-0.0370856493184727,0.232963262957523,0.155164097292897
CD300E,CMRF35-like molecule 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,36075,0.215406122297963,0.0987047233484864,0.0219448645349296,0.408867380060996,0.0291163349339993
CD300E,CMRF35-like molecule 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,36041,0.319365928030139,0.134874922226762,0.0550110804656846,0.583720775594592,0.0179163761633369
CD300E,CMRF35-like molecule 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33255,0.212966902957537,0.0720420134848934,0.0717645565271462,0.354169249387928,0.00313071249767231
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49765,0.106004777472955,0.0623086536558495,-0.0161201836925098,0.22812973863842,0.0889041733258702
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48533,0.0669521985564073,0.036257472109031,-0.00411244677729347,0.138016843890108,0.0648233466679266
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1289.Cooked vegetable intake,51362,-0.142334648106204,0.0273653184537815,-0.195970672275616,-0.0886986239367927,1.99635079721148e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50515,-0.184785442060185,0.0283145348971346,-0.240281930458569,-0.129288953661802,6.89484123195005e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1309.Fresh fruit intake,51219,-0.128077360908979,0.029069445964672,-0.185053474999736,-0.0711012468182216,1.05824708736542e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1319.Dried fruit intake,50220,-0.154174085429806,0.0308723992477379,-0.214683987955372,-0.0936641829042398,5.96285680327336e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X134.Number of self-reported cancers,52452,0.35893370879153,0.0535093432407371,0.254055396039685,0.463812021543375,2.01905057612932e-11
CD300E,CMRF35-like molecule 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52453,0.316854098877245,0.0279725061949202,0.262027986735201,0.371680211019288,1.1440798584466e-29
CD300E,CMRF35-like molecule 2,Health and medical history,"X136.Number of operations, self-reported",52453,0.20663124329433,0.0264675718964687,0.154754802377252,0.258507684211409,6.09835657595151e-15
CD300E,CMRF35-like molecule 2,Health and medical history,X137.Number of treatments or medications taken,52453,0.371238835710319,0.0273098669409482,0.31771149650606,0.424766174914577,6.2654490733419e-42
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1438.Bread intake,51896,0.0129317393253604,0.00309407841122053,0.00686734563936817,0.0189961330113526,2.93200139818342e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1458.Cereal intake,51240,0.0558324097991112,0.0274036987360081,0.00212116027653537,0.109543659321687,0.0416211617419709
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1488.Tea intake,51571,0.0119662514873,0.0030383849359207,0.00601101701289546,0.0179214859617046,8.22828643564613e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1498.Coffee intake,50612,-0.264079510412093,0.0274201594724443,-0.317823022978084,-0.210335997846102,6.54353328189044e-22
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1528.Water intake,50288,-0.0257987924915387,0.027631503808714,-0.0799565399566181,0.0283589549735408,0.350482927363293
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1568.Average weekly red wine intake,46755,-0.381456676059222,0.0309461522686671,-0.442111134505809,-0.320802217612634,8.98809750961033e-35
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46746,-0.149314246415336,0.0323002461437083,-0.212622728857004,-0.0860057639736676,3.81392447983895e-06
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46818,0.0131439344831096,0.0320587698282582,-0.0496912543802765,0.0759791233464958,0.681814456075951
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1598.Average weekly spirits intake,46747,0.00779683198792653,0.0331165444796735,-0.0571115951922334,0.0727052591680865,0.813872881712607
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1608.Average weekly fortified wine intake,46788,-0.0493435600435131,0.0592529952023483,-0.165479430640116,0.0667923105530895,0.404990692880361
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1737.Childhood sunburn occasions,46158,-0.107274214001769,0.0323692634766816,-0.170717970416065,-0.0438304575874726,0.000921324313579766
CD300E,CMRF35-like molecule 2,Health and medical history,X1807.Father's age at death,46354,-0.0110942811780654,0.00355062141069303,-0.0180534991430237,-0.00413506321310701,0.00178332100243255
CD300E,CMRF35-like molecule 2,Health and medical history,X1845.Mother's age,37375,-0.0212518196545456,0.00764338010868408,-0.0362328446675664,-0.00627079464152478,0.00544040476593252
CD300E,CMRF35-like molecule 2,Health and medical history,X1873.Number of full brothers,52042,0.00732564166884588,0.0263034065029056,-0.044229035076849,0.0588803184145408,0.780626850137406
CD300E,CMRF35-like molecule 2,Health and medical history,X1883.Number of full sisters,52044,0.0221626655561072,0.0264070464472864,-0.0295951454805742,0.0739204765927886,0.401325868875754
CD300E,CMRF35-like molecule 2,Physical measures,X20015.Sitting height,52241,-0.00139917548487658,0.00398609342390091,-0.00921191859572237,0.0064135676259692,0.725580806117519
CD300E,CMRF35-like molecule 2,Cognitive function,X20016.Fluid intelligence score,36232,-0.148019115706193,0.0444320628602737,-0.23510595891233,-0.0609322725000566,0.00086834469701447
CD300E,CMRF35-like molecule 2,Cognitive function,X20018.Prospective memory result,36585,0.184032560525033,0.0571851386036824,0.0719496888618151,0.29611543218825,0.00129518305334097
CD300E,CMRF35-like molecule 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36147,0.0158531747721145,0.00539776495436677,0.00527355546155565,0.0264327940826734,0.00332417766238681
CD300E,CMRF35-like molecule 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36146,0.0152869960591816,0.00540667245316484,0.00468991805097855,0.0258840740673847,0.00470466033125114
CD300E,CMRF35-like molecule 2,Cognitive function,X20023.Mean time to correctly identify matches,52142,0.0144817119982475,0.00313487743332472,0.00833735222893103,0.0206260717675639,3.86615111509076e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48959,-0.00841419209899677,0.00695770808578021,-0.022051299947126,0.00522291574913243,0.226548643676883
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48510,-0.0059996496434526,0.0156160661747068,-0.0366071393458779,0.0246078400589727,0.700836361124208
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48469,-0.0208938382542094,0.0204528714912279,-0.060981466377016,0.0191937898685972,0.307001569403511
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48495,-0.00337160396267595,0.0184039697641644,-0.0394433847004382,0.0327001767750864,0.854643101813784
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48515,-0.023032463685216,0.0122896618317974,-0.0471202008755388,0.00105527350510691,0.0609266923025922
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48692,-0.00382289391033824,0.00886904906239803,-0.0212062300726384,0.0135604422519619,0.666445631755888
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48639,0.0127829043221485,0.0112077332543863,-0.00918425285644855,0.0347500615007456,0.254073682650075
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48531,-0.00288994047700712,0.0136250026722542,-0.0295949457146254,0.0238150647606111,0.832026756282691
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48661,0.0185357742077474,0.0105113099536752,-0.00206639330145586,0.0391379417169507,0.0778461824430726
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48751,0.00622776880881632,0.00786322043494387,-0.00918414324367365,0.0216396808613063,0.428362715723756
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48606,0.00280616778754927,0.0107914578526658,-0.0183450896036757,0.0239574251787743,0.794838662396555
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49767,0.0178146926454468,0.00828990393528937,0.00156648093227968,0.034062904358614,0.0316486777597055
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49605,-0.0274278819112623,0.0116257733820906,-0.0502143977401598,-0.00464136608236475,0.0183219649968866
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49526,-0.00214846157438003,0.0257558842768499,-0.0526299947570059,0.0483330716082458,0.933521295026566
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49561,0.0017288489044041,0.0137792696691072,-0.025278519647046,0.0287362174558541,0.900154748851925
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49713,0.0129883446269564,0.00929649646144739,-0.00523278843748052,0.0312094776913932,0.162391411515431
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49603,0.0305110847558122,0.0155559509555547,2.14208829250051e-05,0.0610007486286994,0.0498482493758238
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49569,-0.0129717143853103,0.0141663123798959,-0.0407376866499063,0.0147942578792856,0.359848788876565
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49579,-0.00283764065026757,0.0118410774442082,-0.0260461524409157,0.0203708711403805,0.810608757148765
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49613,0.042525366064277,0.014180584041291,0.0147314213433467,0.0703193107852073,0.00271322827826349
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49815,0.00486505419617125,0.00713900474840481,-0.00912739511070217,0.0188575035030447,0.495578336277122
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49661,0.0211396044899267,0.0106960143216918,0.000175416419410757,0.0421037925604427,0.0481224987918603
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46690,-0.000140367245824976,0.0114047755636144,-0.0224937273505092,0.0222129928588593,0.990180211589369
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46542,0.0130550505615154,0.0457619392730822,-0.0766383504137257,0.102748451536757,0.775431512169033
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46534,-0.030927740340169,0.0455147746760898,-0.120136698705305,0.058281218024967,0.496823602060915
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46589,-0.0247604338958939,0.0149111239940543,-0.0539862369242404,0.00446536913245258,0.096824427402404
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46551,-0.0441602799572193,0.026441360089521,-0.0959853457326805,0.00766478581824197,0.0949127916273809
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46586,0.0229098716645645,0.0191110697858835,-0.0145478251157671,0.0603675684448961,0.230631260622326
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46557,0.0413440376562661,0.0218642698414049,-0.00150993123288753,0.0841980065454197,0.0586483429675822
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46561,0.0428351786412735,0.0212231773260097,0.00123775108229444,0.0844326062002526,0.0435727049224614
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46567,-0.0125757464661592,0.0168249281154545,-0.04555260557245,0.0204011126401317,0.454803407110737
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46584,0.0442625904675349,0.0213667746616074,0.00238371213078446,0.0861414688042853,0.0383205655425683
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46755,-0.000482514364718392,0.00867917289979687,-0.0174936932483203,0.0165286645188835,0.95566544987533
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46655,0.0264068128330958,0.0120710913822069,0.00274747372397028,0.0500661519422213,0.0287109655582351
CD300E,CMRF35-like molecule 2,Mental health,X20127.Neuroticism score,47816,0.0542160470271105,0.0274437934035806,0.000426211956092548,0.108005882098128,0.0482222861758174
CD300E,CMRF35-like molecule 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36232,-0.0186378664238772,0.0448635937285154,-0.106570510131767,0.0692947772840131,0.677835848060022
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20161.Pack years of smoking,36915,0.0386678956037589,0.00536852636671616,0.0281455839249953,0.0491902072825226,6.41824929401638e-13
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36915,0.0380676698297124,0.00529220845126338,0.0276949412652362,0.0484403983941887,6.88068238162453e-13
CD300E,CMRF35-like molecule 2,Cognitive function,X20191.Fluid intelligence score,34280,-0.0523895774272913,0.0532081679392308,-0.156677586588184,0.0518984317336011,0.324855087537507
CD300E,CMRF35-like molecule 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34281,-0.0605132977741772,0.0542590682352228,-0.166861071515214,0.0458344759668596,0.264783695458617
CD300E,CMRF35-like molecule 2,Cognitive function,X20240.Maximum digits remembered correctly,33735,-0.0815266614299025,0.0568163824292407,-0.192886770991214,0.0298334481314093,0.15137240641063
CD300E,CMRF35-like molecule 2,Physical measures,X20255.Spirometry QC measure,45615,0.0139812507803839,0.0343332056559059,-0.0533118323051916,0.0812743338659594,0.68384976519216
CD300E,CMRF35-like molecule 2,Eye measures,X20261.avMSE,33841,0.0149808818230083,0.00660117038666818,0.00204258786513871,0.027919175780878,0.0232827615623776
CD300E,CMRF35-like molecule 2,Eye measures,X20262.Myopia diagnosis,33841,-0.0233172997902871,0.0678683858978483,-0.15633933615007,0.109704736569496,0.73118615022898
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20280.Glucose-lactate,42205,-0.00747013691425002,0.0039684168897954,-0.015248234018249,0.000307960189748956,0.0598034258822839
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42229,-0.0133179594293169,0.00420254298281109,-0.0215549436756267,-0.00508097518300718,0.00153289803936949
CD300E,CMRF35-like molecule 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35971,-0.0374787265803304,0.025633481208764,-0.0877203497495079,0.0127628965888471,0.14375629379054
CD300E,CMRF35-like molecule 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35971,-0.0259548116998395,0.0557885953071472,-0.135300458501848,0.0833908351021689,0.641776862290158
CD300E,CMRF35-like molecule 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35971,0.0117680124482298,0.0693885755325392,-0.124233595595547,0.147769620492007,0.865332663200248
CD300E,CMRF35-like molecule 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35971,-0.0425065942931004,0.0249263725546742,-0.0913622845002618,0.00634909591406094,0.0881832309129476
CD300E,CMRF35-like molecule 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35971,-0.0614674709529997,0.0352929120401629,-0.130641578551719,0.00770663664571956,0.0816135520748062
CD300E,CMRF35-like molecule 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35974,-0.0299808338931168,0.0476898069722422,-0.123452855558711,0.063491187772478,0.529588947569543
CD300E,CMRF35-like molecule 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35974,-0.0230002907452254,0.0301299866430334,-0.0820550645655708,0.0360544830751201,0.445267922660885
CD300E,CMRF35-like molecule 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35974,-0.0264605162720853,0.034368782609877,-0.0938233301874441,0.0409022976432735,0.441384039429847
CD300E,CMRF35-like molecule 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35974,0.0248178675259789,0.0501115842178351,-0.0734008375409779,0.123036572592936,0.620436932259269
CD300E,CMRF35-like molecule 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35974,0.0775791207623539,0.0561763672833382,-0.0325265591129889,0.187684800637697,0.16732323179898
CD300E,CMRF35-like molecule 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35974,-0.0225823099563069,0.0363154977250357,-0.0937606854973769,0.0485960655847631,0.534068463369158
CD300E,CMRF35-like molecule 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35974,0.0217885483042233,0.0542836621971916,-0.0846074296022722,0.128184526210719,0.688149670894024
CD300E,CMRF35-like molecule 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35974,0.00360689543363904,0.0440755712650084,-0.0827812242457774,0.0899950151130555,0.934780666589406
CD300E,CMRF35-like molecule 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35977,-0.0355526744803557,0.0754387853027773,-0.183412693673799,0.112307344713088,0.637455832680229
CD300E,CMRF35-like molecule 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35977,-0.0612279213761693,0.0327486399517612,-0.125415255681621,0.00295941292928278,0.0615744524578184
CD300E,CMRF35-like molecule 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35977,-0.0428360906165514,0.0432271197132368,-0.127561245254495,0.0418890640213927,0.321740505266994
CD300E,CMRF35-like molecule 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35977,0.0880793630107907,0.0912642693531877,-0.0907986049214572,0.266957330943039,0.33452517396254
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20600.Liking for adding salt to foods,36673,-0.0176604610857516,0.0460984145507461,-0.108013353605214,0.0726924314337107,0.701653169020969
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20601.Liking for aniseed,36673,0.026077297393847,0.0456681590748734,-0.0634322943929049,0.115586889180599,0.568003998731797
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20602.Liking for apple juice,36673,0.0803385374807669,0.046259388680182,-0.0103298643323898,0.171006939293924,0.0824788703752712
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20603.Liking for apples,36673,-0.00744999484808404,0.0466750355836357,-0.0989330645920099,0.0840330748958418,0.873189050950222
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20604.Liking for asparagus,36673,-0.246807420584182,0.0461568341873809,-0.337274815591449,-0.156340025576916,9.17990754133002e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20605.Liking for aubergine,36673,-0.270688680742123,0.045324546040711,-0.359524790981917,-0.18185257050233,2.43948051549966e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20606.Liking for avocados,36673,-0.245287528210525,0.0455220041577055,-0.334510656359628,-0.156064400061423,7.31238304408207e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20607.Liking for bacon,36673,-0.0954684579192889,0.0465992283649908,-0.186802945514671,-0.00413397032390692,0.0405224597015224
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36673,-0.144438557555755,0.0461514875274975,-0.23489547310965,-0.0539816420018601,0.00175632082164694
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20609.Liking for bananas,36673,0.0136082286836171,0.0472779754424163,-0.0790566031835188,0.106273060550753,0.773480884526796
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36673,-0.11533763402456,0.0462441491783322,-0.205976166414091,-0.0246991016350284,0.0126474868621224
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20611.Liking for beef steak,36673,-0.0388773234539101,0.0464823124549256,-0.129982655865564,0.0522280089577441,0.402960535597678
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20612.Liking for beetroot,36673,-0.110353070429154,0.0459901144381683,-0.200493694727964,-0.0202124461303445,0.0164402313935384
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20613.Liking for bell pepper,36673,-0.122654774183257,0.0454506121796888,-0.211737974055447,-0.0335715743110669,0.00697687732560208
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20614.Liking for bicycling,36673,-0.178819790269385,0.045785954976546,-0.268560262023415,-0.0890793185153552,9.4774749107761e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20615.Liking for biscuits,36673,0.190917812392554,0.0463950913963618,0.0999834332556845,0.281852191529423,3.90960109090877e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20616.Liking for bitter foods,36673,-0.193999551751546,0.0461020764853553,-0.284359621662843,-0.10363948184025,2.603835467148e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20617.Liking for bitter or ale,36673,-0.248858229392129,0.0458898905796436,-0.338802414928231,-0.158914043856028,6.032337500856e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20618.Liking for black olives,36673,-0.235645487390756,0.0457813067265423,-0.325376848574779,-0.145914126206733,2.7064600514763e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20619.Liking for black pepper,36673,-0.188324797203142,0.0460123211918034,-0.278508946739076,-0.0981406476672068,4.30126966960494e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20620.Liking for blue cheese,36673,-0.22843930712749,0.0457717508388602,-0.318151938771656,-0.138726675483324,6.13767549033415e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20621.Liking for bolognese sauce,36673,-0.163880012667504,0.046397870173904,-0.254819838208356,-0.0729401871266525,0.000414642419280822
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20622.Liking for broad beans,36673,-0.116573076278123,0.0457783935202993,-0.20629872757791,-0.0268474249783362,0.0109004411390989
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20623.Liking for broccoli,36673,-0.15001174906457,0.046456901345115,-0.241067275700996,-0.0589562224281449,0.00124698701480954
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20624.Liking for brown rice,36673,-0.187608440174642,0.045721984200174,-0.277223529206983,-0.0979933511423008,4.11409166042821e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20625.Liking for brussel sprouts,36673,-0.137084284338769,0.0458284130464359,-0.226907973909783,-0.0472605947677544,0.00278677109700132
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20626.Liking for burgers (meat),36673,-0.041674880075972,0.0454949856526415,-0.130845051955149,0.0474952918032053,0.359677303053168
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36673,-0.1077137392002,0.0456275563595417,-0.197143749664902,-0.018283728735498,0.0182633161731169
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20628.Liking for butter on bread,36673,0.0189826216307482,0.0461529759146231,-0.0714772111619132,0.10944245442341,0.68086504627604
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20629.Liking for butternut squash,36673,-0.157964859489468,0.04528566920835,-0.246724771137834,-0.0692049478411021,0.000488903159075036
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20630.Liking for cabbage,36673,-0.162210858637143,0.0462150652679078,-0.252792386562242,-0.0716293307120434,0.000450700837502556
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20631.Liking for cake,36673,0.140321055740954,0.0461517071481662,0.0498637097305484,0.23077840175136,0.00236998412458811
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20632.Liking for cake icing,36673,0.173292624712752,0.0453368228224217,0.0844324519808055,0.262152797444699,0.000133187258881573
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20633.Liking for capers,36673,-0.288743308104141,0.0454586737436066,-0.37784230864161,-0.199644307566672,2.24375380024328e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20634.Liking for cauliflower,36673,-0.181003380421233,0.0462391809270203,-0.271632175038193,-0.0903745858042735,9.13367066191918e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36673,0.0588786187465891,0.0454611886601065,-0.0302253110272195,0.147982548520398,0.19530890246161
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20636.Liking for cheesecake,36673,0.0282487259799744,0.0458878382860231,-0.0616914370606308,0.11818888902058,0.538173439669881
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20637.Liking for cherries,36673,-0.11191417917721,0.0468009153477332,-0.203643973258767,-0.0201843850956534,0.0168124419196835
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20638.Liking for chicken,36673,-0.024696534045204,0.0475435529957247,-0.117881897916824,0.0684888298264163,0.60346070861149
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20639.Liking for chilli pepper,36673,-0.172642065917432,0.045523187373245,-0.261867513168992,-0.083416618665872,0.0001502888674072
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20640.Liking for chips or french fries,36673,0.0570109980154565,0.0465556075772279,-0.0342379928359101,0.148259988866823,0.220769828737486
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20641.Liking for cigarette smoking,36673,-0.0342433279433928,0.0713268249082527,-0.174043904763568,0.105557248876782,0.63117609567233
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20642.Liking for cod,36673,-0.102697338783869,0.0472156671314572,-0.195240046361525,-0.0101546312062125,0.0296538966018215
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20643.Liking for coffee with sugar,36673,0.198065933986736,0.0476734991857763,0.104625875582615,0.291505992390858,3.29172708209041e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20644.Liking for coffee without sugar,36673,-0.325040441401819,0.0462528223217739,-0.415695973152496,-0.234384909651143,2.27443889470263e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20645.Liking for coriander,36673,-0.234820117388514,0.0455437609665727,-0.324085888882996,-0.145554345894031,2.58381555590133e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20646.Liking for corn flakes,36673,0.208268005972038,0.0457417419570091,0.118614191736301,0.297921820207776,5.36294150305438e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20647.Liking for cream,36673,-0.0185412287350176,0.0459414186942366,-0.108586409375721,0.0715039519056862,0.686529238806632
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20648.Liking for croissant,36673,0.00288207887386759,0.0458187184401712,-0.0869226092688681,0.0926867670166032,0.949846277676588
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20649.Liking for cucumber,36673,-0.0707754404449026,0.0458950173974434,-0.160729674543892,0.0191787936540864,0.123084646895379
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20650.Liking for curry,36673,-0.0962500881782785,0.0465175743290411,-0.187424533863199,-0.00507564249335794,0.0385673291451947
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20651.Liking for dairy products,36673,0.0272096515257275,0.0465698046092804,-0.0640671655084621,0.118486468559917,0.559050513029695
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20652.Liking for dark chocolate,36673,-0.043097234700673,0.0463909101669364,-0.134023418627868,0.0478289492265223,0.352916008725555
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36673,0.123781199074014,0.0468151463813056,0.0320235121666552,0.215538885981373,0.00820811663938778
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20654.Liking for dried fruit,36673,-0.0926299129804485,0.0463011428760768,-0.183380153017559,-0.001879672943338,0.0454693355878283
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20655.Liking for eggs,36673,-0.122051509546585,0.0472022666836693,-0.214567952246577,-0.0295350668465937,0.00973515944543751
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20656.Liking for exercising alone,36673,-0.208322125207325,0.045792328026457,-0.29807508813918,-0.118569162275469,5.46168268992738e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20657.Liking for exercising with others,36673,-0.186006217470059,0.0456227031677336,-0.275426715678817,-0.0965857192613015,4.60481968685515e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36673,-0.198236306017877,0.0459024274619218,-0.288205063843244,-0.10826754819251,1.58869290639117e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20659.Liking for fatty foods,36673,-0.0199420071891398,0.045258087802606,-0.108647859282248,0.0687638449039678,0.659493716394115
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36673,-0.222781559813764,0.0479219157323199,-0.316708514649111,-0.128854604978417,3.39104594988216e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20661.Liking for fried chicken,36673,-0.00990505486912586,0.0454776742635769,-0.0990412964257366,0.0792311866874849,0.82759015691534
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20662.Liking for fried or battered fish,36673,-0.0591055148163524,0.0460319188264765,-0.149328075716246,0.0311170460835415,0.199174808774229
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20663.Liking for fruit,36673,-0.0786369876489513,0.0484752128057329,-0.173648404748188,0.0163744294502851,0.10479742718282
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20664.Liking for garlic,36673,-0.196477194708825,0.0464035827397325,-0.287428216878701,-0.105526172538949,2.32020589672985e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20665.Liking for gherkins,36673,-0.187540231410476,0.045413764109793,-0.27655120906567,-0.0985292537552817,3.67077104919731e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20666.Liking for globe artichoke,36673,-0.234757369269676,0.0456967491708148,-0.324322997644473,-0.145191740894879,2.85261151820548e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20667.Liking for goat's cheese,36673,-0.17945752692946,0.0454492223344047,-0.268538002704893,-0.0903770511540266,7.9302202980144e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20668.Liking for going to a cafe,36673,-0.0484719012300265,0.0457144396420934,-0.13807220292853,0.0411284004684765,0.289031132131208
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20669.Liking for going to the gym,36673,-0.16949217960689,0.0454230676632261,-0.258521392226813,-0.0804629669869669,0.000191717618626607
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20670.Liking for going to the pub,36673,-0.200332546077827,0.0456247257137053,-0.28975700847669,-0.110908083678965,1.14334889094521e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20671.Liking for grapefruit,36673,-0.0599754330744245,0.0459395288925689,-0.15001690970386,0.0300660435550106,0.191749684154706
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20672.Liking for green olives,36673,-0.263241424758203,0.0457315574145451,-0.352875277290711,-0.173607572225694,8.91625539100849e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20673.Liking for haddock,36673,-0.20147083058885,0.0470893258251262,-0.293765909206098,-0.109175751971603,1.90345867872206e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20674.Liking for ham,36673,-0.046505571183308,0.0464467463578607,-0.137541194044715,0.0445300516780989,0.316728027260457
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20675.Liking for hard cheese,36673,-0.0974599608995822,0.0466547438572009,-0.188903258859696,-0.00601666293946844,0.0367424688057491
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20676.Liking for herring,36673,-0.190096949256701,0.0457645601168822,-0.27979548708579,-0.100398411427611,3.30368826377089e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20677.Liking for honey,36673,-0.00849202339152652,0.0460099459919595,-0.0986715175357672,0.0816874707527142,0.85357151074219
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36673,-0.187102152265753,0.0454754276738314,-0.276233990506463,-0.0979703140250436,3.92122338745535e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20679.Liking for ice cream,36673,0.034287131202873,0.0464922906801654,-0.0568377585302512,0.125412020935997,0.460852002380226
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20680.Liking for jam,36673,0.112564389410424,0.0458574923876009,0.0226837043307261,0.202445074490121,0.0141229045516007
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20681.Liking for kiwi fruit,36673,-0.105089285874296,0.0457923345601337,-0.194842261612158,-0.015336310136434,0.0217638442086469
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20682.Liking for lager,36673,-0.144293311604486,0.0456153409567358,-0.233699379879688,-0.0548872433292837,0.0015659050093166
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20683.Liking for lamb,36673,-0.141577660485034,0.0465979429967779,-0.232909628758718,-0.0502456922113489,0.00238693330359507
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20684.Liking for lemons,36673,-0.170174700484139,0.0460769939202404,-0.260485608567811,-0.0798637924004682,0.000222853444051294
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20685.Liking for lentils or beans,36673,-0.139792554109355,0.046152619393097,-0.230251688119826,-0.0493334200988854,0.00246207129918696
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20686.Liking for liver,36673,-0.229931481725491,0.0455661204461258,-0.319241077799898,-0.140621885651085,4.60755691695855e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20687.Liking for mackerel,36673,-0.252113218561786,0.0461780597775864,-0.342622215725855,-0.161604221397716,4.91426959474813e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20688.Liking for marzipan,36673,0.0778733783358522,0.0456905837257971,-0.0116801657667101,0.167426922438415,0.088351659058683
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20689.Liking for mayonnaise,36673,-0.12269188428372,0.0458060214638214,-0.21247168635281,-0.0329120822146296,0.0074100492810178
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20690.Liking for melon,36673,-0.0526680609817495,0.0466301855078732,-0.144063224577181,0.038727102613682,0.258727198591816
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20691.Liking for milk chocolate,36673,0.119071345137714,0.0456757980198653,0.0295467810187777,0.20859590925665,0.00915394384393761
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20692.Liking for mushrooms,36673,-0.203913512902434,0.0471958916008182,-0.296417460440038,-0.111409565364831,1.57487607649769e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20694.Liking for orange juice,36673,0.0874432412223168,0.0465392514087532,-0.0037736915388394,0.178660173983473,0.060292305133117
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20695.Liking for oranges,36673,-0.0903127344535976,0.0466021527063839,-0.18165295375811,0.00102748485091485,0.0526639439403093
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20696.Liking for pasta,36673,-0.0784197443818255,0.0469696065057296,-0.170480173133056,0.0136406843694046,0.0950403398276015
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20697.Liking for pears,36673,0.0577776503422663,0.0467100095097028,-0.0337739682967511,0.149329268981284,0.216144018337217
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20698.Liking for pizza,36673,0.0123686997244716,0.0460486177039447,-0.0778865909752601,0.102623990424203,0.788243697864666
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20699.Liking for plain yogurt,36673,-0.0957412524977722,0.0458110896494389,-0.185530988210672,-0.00595151678487195,0.036656746173963
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20700.Liking for plums,36673,-0.0348805417795737,0.0468606973911406,-0.126727508666209,0.0569664251070619,0.456689266849752
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20701.Liking for pollock,36673,-0.171966283734956,0.0455559657100224,-0.2612559765266,-0.0826765909433119,0.000161262191078666
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20702.Liking for pork chop,36673,-0.118417066981252,0.0460323762653715,-0.20864052446138,-0.0281936095011238,0.0101151971691803
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20703.Liking for porridge,36673,-0.0198310877672764,0.0459969929808573,-0.109985194009757,0.070323018475204,0.666378983740253
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20704.Liking for potato crisps,36673,0.0118593576991038,0.0458478053394138,-0.0780023407661473,0.101721056164355,0.79589805414121
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20705.Liking for potatoes,36673,0.0348786935760471,0.0468539148740575,-0.0569549795771055,0.1267123667292,0.456647955280076
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20706.Liking for prawns,36673,-0.269472581345902,0.0462913525798112,-0.360203632402332,-0.178741530289472,6.06529130499331e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20707.Liking for raw carrots,36673,-0.0603913757133719,0.0456781519399138,-0.149920553515603,0.0291378020888592,0.186170232125286
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20708.Liking for red meat,36673,-0.05249683084643,0.0466041321602018,-0.143840929880425,0.0388472681875655,0.260012188010836
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20709.Liking for red wine,36673,-0.36278816339956,0.0464385333307906,-0.45380768872791,-0.271768638071211,6.32657726029942e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36673,0.16917662346716,0.0461499891457418,0.0787226447415064,0.259630602192814,0.000248151197714727
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20711.Liking for roast chicken,36673,-0.0635436042186704,0.0476133565184688,-0.156865782994869,0.0297785745575285,0.182053103675556
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20712.Liking for salad dressing,36673,-0.081325857985795,0.0456339186219152,-0.170768338484749,0.00811662251315866,0.0747646411075614
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20713.Liking for salad leaves,36673,-0.141444392310771,0.0458338029815392,-0.231278646154588,-0.0516101384669546,0.00203537338872912
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20714.Liking for salami,36673,-0.195179725141913,0.0454717835636177,-0.284304420926604,-0.106055029357223,1.78878788645076e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20715.Liking for salmon,36673,-0.213368234572569,0.0467727295403037,-0.305042784471564,-0.121693684673574,5.14643186870304e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20716.Liking for salty foods,36673,-0.0206626792137018,0.0456808885735281,-0.110197220817817,0.0688718623904134,0.651045911427131
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20717.Liking for salty pretzels,36673,-0.0840827020331669,0.04564750541187,-0.173551812640432,0.00538640857409825,0.0655118547600115
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20718.Liking for sardines,36673,-0.228378994357627,0.0458795070695929,-0.318302828214029,-0.138455160501225,6.56435622926358e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20719.Liking for sausages (meat),36673,-0.0413877326737109,0.0461878339798295,-0.131915887274177,0.0491404219267549,0.370239810371081
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20720.Liking for savoury biscuits,36673,-0.0387391572219806,0.0461119779438584,-0.129118633991943,0.0516403195479819,0.400871335722127
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36673,-0.323275788159707,0.0458720203044979,-0.413184947956523,-0.233366628362891,1.97399581184995e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20722.Liking for skimmed milk,36673,-0.0193661246664449,0.0455627507927158,-0.108669116220168,0.0699368668872782,0.670816727581959
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20723.Liking for smoked fish,36673,-0.237091302494782,0.0460963531506047,-0.327440154669967,-0.146742450319597,2.76182133648338e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20724.Liking for soft cheese,36673,-0.130561487130754,0.0455521547689497,-0.219843710477896,-0.041279263783613,0.00416509848323218
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20725.Liking for soy sauce,36673,-0.108512728538944,0.0459229005681424,-0.198521613652503,-0.0185038434253847,0.0181545555443659
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20726.Liking for soya milk,36673,-0.0864723055424785,0.0457795697365552,-0.176200262226127,0.00325565114116973,0.058943199708534
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20727.Liking for spicy foods,36673,-0.0947188459950088,0.0458852693594455,-0.184653973939522,-0.00478371805049552,0.0390255588108024
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20728.Liking for spinach,36673,-0.223583897850087,0.046026569091969,-0.313795973270346,-0.133371822429827,1.20986461628402e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20729.Liking for spirits,36673,-0.149450955222376,0.0455022124071268,-0.238635291540345,-0.0602666189044078,0.00102607708946338
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20730.Liking for strawberries,36673,-0.023090472356923,0.0475731858655519,-0.116333916653405,0.0701529719395587,0.627428956296465
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36673,0.132128652227223,0.0459520782080646,0.0420625789394159,0.222194725515029,0.00404627030879034
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20732.Liking for sweet foods,36673,0.204331546331368,0.0457264063467814,0.114707789891676,0.293955302771059,7.98197549252907e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20733.Liking for taking the stairs,36673,-0.228442129652529,0.0468607981942858,-0.320289294113329,-0.136594965191728,1.10938102633365e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20734.Liking for tea with sugar,36673,0.26459628384859,0.0498639090777952,0.166863022056111,0.362329545641068,1.14804131359591e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20735.Liking for tea without sugar,36673,-0.225524046605667,0.046477969521532,-0.31662086686787,-0.134427226343464,1.24340945552621e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20736.Liking for tomato ketchup,36673,0.0786065231759666,0.0459123102086838,-0.0113816048330538,0.168594651184987,0.0869164609339828
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20737.Liking for tinned tuna,36673,-0.1556441310533,0.0459973900371577,-0.24579901552613,-0.0654892465804715,0.000718410465131851
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20738.Liking for turnip (white),36673,-0.135432466324129,0.0453499990800273,-0.224318464520983,-0.0465464681272757,0.00283147316877798
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20739.Liking for vegetables,36673,-0.103711931789355,0.0477550416735036,-0.197311813469422,-0.0101120501092874,0.0299037013789107
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20740.Liking for vinegar,36673,-0.0846026417427385,0.046019806802715,-0.17480146307606,0.00559617959058298,0.0660407885669605
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20741.Liking for watching television,36673,0.158188952546403,0.0464705873127974,0.0671066014133198,0.249271303679486,0.000667140444366827
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20742.Liking for whisky,36673,-0.148557717091338,0.0456554284735489,-0.238042356899494,-0.0590730772831825,0.00114305543961945
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20743.Liking for white bread,36673,0.146479843376998,0.045256809129829,0.0577764974825335,0.235183189271463,0.00121435906877787
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20744.Liking for white rice,36673,0.0233945222844594,0.0464081982635601,-0.0675655463121184,0.114354590881037,0.614202614744766
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20745.Liking for white wine,36673,-0.163622677646788,0.0453227051324078,-0.252455179706308,-0.0747901755872688,0.000307852835427542
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36673,-0.0926841638168427,0.0465939244746585,-0.184008255787173,-0.00136007184651196,0.0467139764143969
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20747.Liking for whole milk,36673,0.052794020251014,0.0454625740284183,-0.0363126248446858,0.141900665346714,0.245569198556665
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20748.Liking for wholemeal bread,36673,-0.212418427179048,0.0472564509408841,-0.305041071023181,-0.119795783334915,7.05364513251216e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20749.Liking for working up a sweat,36673,-0.299587171835101,0.046198158854097,-0.390135563189131,-0.20903878048107,9.40626550131016e-11
CD300E,CMRF35-like molecule 2,Physical measures,X21001.Body mass index (BMI),52314,-0.138192088210425,0.0159068723174083,-0.169369557952545,-0.107014618468305,3.93757977737721e-18
CD300E,CMRF35-like molecule 2,Physical measures,X21002.Weight,52346,0.00785556401548732,0.00770422443870969,-0.00724471588438368,0.0229558439153583,0.307907853324818
CD300E,CMRF35-like molecule 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36571,0.0137970038037304,0.00576526090507858,0.00249709242977641,0.0250969151776844,0.0167284352301196
CD300E,CMRF35-like molecule 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36421,0.0812126301632408,0.0496214064085861,-0.016045326397588,0.17847058672407,0.101744912764901
CD300E,CMRF35-like molecule 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36423,-0.0287009267785153,0.0510376204430075,-0.12873466284681,0.0713328092897794,0.573894752495994
CD300E,CMRF35-like molecule 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36424,-0.00164941454660764,0.0493989661285281,-0.0984713881585228,0.0951725590653075,0.973364709448292
CD300E,CMRF35-like molecule 2,Health and medical history,X21040.Satisfaction with bowel habits,36396,0.126787591881403,0.0459528557939805,0.0367199945252018,0.216855189237605,0.00580997902514504
CD300E,CMRF35-like molecule 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36395,0.170944035336408,0.0502182942556325,0.0725161785953686,0.269371892077448,0.000667370696576587
CD300E,CMRF35-like molecule 2,Health and medical history,X21042.Greatest number of times bowels opened per day,36392,-0.041499962915896,0.0493824715710162,-0.138289607195088,0.0552896813632957,0.400722039540245
CD300E,CMRF35-like molecule 2,Health and medical history,X21043.Least number of times bowels opened per week,36359,0.00362341651818325,0.0496017215658932,-0.0935959577509674,0.100842790787334,0.941768040130655
CD300E,CMRF35-like molecule 2,Health and medical history,X21044.Average number of times bowels opened per day,36367,0.0962184019521047,0.0541118199210184,-0.0098407650930914,0.202277568997301,0.0754199842219751
CD300E,CMRF35-like molecule 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36430,0.0137938963111082,0.0496396579453429,-0.0834998332617639,0.11108762588398,0.78111137938709
CD300E,CMRF35-like molecule 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36426,-0.051751655574699,0.049533754935689,-0.14883781524865,0.0453345040992515,0.296158995639089
CD300E,CMRF35-like molecule 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36428,-0.023704649989706,0.0574188441581994,-0.136245584539777,0.0888362845603648,0.679737009521827
CD300E,CMRF35-like molecule 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36428,-0.178237899378973,0.0709531458038926,-0.317306065154603,-0.0391697336033439,0.0120231419362984
CD300E,CMRF35-like molecule 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36428,-0.183601887481333,0.0602076319936126,-0.301608846188814,-0.0655949287738523,0.00230005224084777
CD300E,CMRF35-like molecule 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36426,-0.277624583177547,0.14057914616482,-0.553159709660594,-0.00208945669449917,0.0483187707097653
CD300E,CMRF35-like molecule 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36430,-0.0836259278594998,0.0614893421012139,-0.204145038377879,0.0368931826588794,0.173866909506485
CD300E,CMRF35-like molecule 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36427,-0.331804179237584,0.0561177013784977,-0.44179487393944,-0.221813484535729,3.50787057708794e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36282,0.115517344791059,0.0561496988840562,0.0054639349783092,0.22557075460381,0.0396900914066514
CD300E,CMRF35-like molecule 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36424,-0.00399317264320306,0.0507042107369668,-0.103373425687658,0.0953870804012519,0.937230099718869
CD300E,CMRF35-like molecule 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36429,-0.0928652556622623,0.085851732391103,-0.261134651148824,0.0754041398242996,0.279422090226896
CD300E,CMRF35-like molecule 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36430,-0.215841279229489,0.050022104374079,-0.313884603802684,-0.117797954656294,1.6162476676831e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36429,-0.0373114325282663,0.0495841530163436,-0.1344963724403,0.0598735073837671,0.451780847328139
CD300E,CMRF35-like molecule 2,Working and living environment,X21100.Water hardness (USGS classification),52180,0.0239223099995393,0.0264930655042213,-0.0280040983887343,0.075848718387813,0.366553713421958
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2139.Age first had sexual intercourse,49316,-0.000745923879951014,0.00313110854112973,-0.00688289662056528,0.00539104886066325,0.81170509312591
CD300E,CMRF35-like molecule 2,Health and medical history,X2149.Lifetime number of sexual partners,47631,-0.0948751384058811,0.030542321457488,-0.154738088462558,-0.0350121883492046,0.00189690934713679
CD300E,CMRF35-like molecule 2,Physical activities,X22032.IPAQ activity group,48526,-0.266035404763786,0.0291277212659743,-0.323125738445095,-0.208945071082476,7.25641423768166e-20
CD300E,CMRF35-like molecule 2,Physical activities,X22033.Summed days activity,48935,-0.0337702177790261,0.00309471291737514,-0.0398358550970814,-0.0277045804609708,1.20209733492036e-27
CD300E,CMRF35-like molecule 2,Physical activities,X22034.Summed minutes activity,48526,-0.0259659561353821,0.00313903245738316,-0.0321184597518531,-0.0198134525189111,1.3996462668042e-16
CD300E,CMRF35-like molecule 2,Physical activities,X22037.MET minutes per week for walking,47801,-0.0187940014808881,0.0032003821195448,-0.0250667504351959,-0.0125212525265803,4.36548530245831e-09
CD300E,CMRF35-like molecule 2,Physical activities,X22038.MET minutes per week for moderate activity,48526,-0.0219743768794302,0.00318735955658812,-0.0282216016103429,-0.0157271521485175,5.57792416762864e-12
CD300E,CMRF35-like molecule 2,Physical activities,X22039.MET minutes per week for vigorous activity,48526,-0.314613044172119,0.0293817782475815,-0.372201329537378,-0.257024758806859,1.10629520907231e-26
CD300E,CMRF35-like molecule 2,Physical activities,X22040.Summed MET minutes per week for all activity,47801,-0.0272281685184702,0.00316911918455427,-0.0334396421201966,-0.0210166949167439,9.21392675811518e-18
CD300E,CMRF35-like molecule 2,Eye measures,X2217.Age started wearing glasses or contact lenses,48591,-0.0014392066226528,0.0032932526016625,-0.00789398172191131,0.0050155684766057,0.662103904710686
CD300E,CMRF35-like molecule 2,Working and living environment,X22501.Year ended full time education,34204,-0.0445393326205659,0.0139960845495859,-0.0719716583377542,-0.0171070069033776,0.00146923347042238
CD300E,CMRF35-like molecule 2,Lifestyle factors,X22506.Tobacco smoking,34166,-0.151046597980212,0.109562442994333,-0.365788986249105,0.0636957902886803,0.168062801729737
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50962,-0.00733494635846361,0.0830976613289934,-0.170206362563291,0.155536469846363,0.929663678232717
CD300E,CMRF35-like molecule 2,Physical measures,X23098.Weight,51901,0.0107226459954206,0.00773734150982265,-0.00444254336383177,0.025887835354673,0.165811845010582
CD300E,CMRF35-like molecule 2,Physical measures,X23099.Body fat percentage,51871,0.0617137607945231,0.00687331248453317,0.0482420683248381,0.0751854532642081,2.94120505776529e-19
CD300E,CMRF35-like molecule 2,Physical measures,X23100.Whole body fat mass,51827,0.0615842835158874,0.00686457061862928,0.0481297251033741,0.0750388419284008,3.14618579460881e-19
CD300E,CMRF35-like molecule 2,Physical measures,X23101.Whole body fat-free mass,51895,-0.0169293117744845,0.00667718022494599,-0.0300165850153786,-0.00384203853359032,0.0112384340619235
CD300E,CMRF35-like molecule 2,Physical measures,X23102.Whole body water mass,51901,-0.0170722538006975,0.00666061273746325,-0.0301270547661255,-0.00401745283526952,0.0103784749070638
CD300E,CMRF35-like molecule 2,Physical measures,X23104.Body mass index (BMI),51901,-0.117573416658709,0.0156705629842964,-0.14828772010793,-0.086859113209488,6.46931101967908e-14
CD300E,CMRF35-like molecule 2,Physical measures,X23105.Basal metabolic rate,51901,-0.0139865234331629,0.00693911969638968,-0.0275871980380867,-0.000385848828239135,0.0438527683009639
CD300E,CMRF35-like molecule 2,Physical measures,X23106.Impedance of whole body,51901,0.071311379394684,0.00544455975371885,0.060640042277395,0.0819827165119729,4.6619461905243e-39
CD300E,CMRF35-like molecule 2,Physical measures,X23107.Impedance of leg (right),51901,0.0170723194157207,0.00441296196042513,0.00842291397328747,0.025721724858154,0.000109725659348379
CD300E,CMRF35-like molecule 2,Physical measures,X23108.Impedance of leg (left),51901,0.0210579125854932,0.00440069786102157,0.0124325447778909,0.0296832803930955,1.71922805870746e-06
CD300E,CMRF35-like molecule 2,Physical measures,X23109.Impedance of arm (right),51901,0.0874391487779396,0.0053795839314026,0.0768951642723905,0.0979831332834886,4.43306280456166e-59
CD300E,CMRF35-like molecule 2,Physical measures,X23110.Impedance of arm (left),51901,0.0868841435984488,0.00537505186275719,0.0763490419474447,0.0974192452494529,1.87252048725558e-58
CD300E,CMRF35-like molecule 2,Physical measures,X23111.Leg fat percentage (right),51901,-0.0111945444911351,0.00702034084426097,-0.0249544125458866,0.00256532356361641,0.110818176397875
CD300E,CMRF35-like molecule 2,Physical measures,X23112.Leg fat mass (right),51901,0.0111160226791088,0.00756716747795981,-0.00371562557769243,0.02594767093591,0.14185153485862
CD300E,CMRF35-like molecule 2,Physical measures,X23113.Leg fat-free mass (right),51900,0.0152255435056879,0.00734155306092831,0.000836099506268426,0.0296149875051074,0.0381008651531915
CD300E,CMRF35-like molecule 2,Physical measures,X23114.Leg predicted mass (right),51900,0.0167466561163383,0.00739537247950101,0.00225172605651637,0.0312415861761603,0.0235538973258509
CD300E,CMRF35-like molecule 2,Physical measures,X23115.Leg fat percentage (left),51900,-0.0123679892308918,0.0073485170152835,-0.0267710825808475,0.00203510411906385,0.0923770273456681
CD300E,CMRF35-like molecule 2,Physical measures,X23116.Leg fat mass (left),51900,0.0172699528828449,0.00800910535075283,0.00157210639536937,0.0329677993703204,0.031071236810015
CD300E,CMRF35-like molecule 2,Physical measures,X23117.Leg fat-free mass (left),51899,0.0161570451602999,0.00799317263314691,0.000490426799331981,0.0318236635212679,0.0432543668005938
CD300E,CMRF35-like molecule 2,Physical measures,X23118.Leg predicted mass (left),51899,0.017489250703477,0.00805613193605032,0.00169923210881835,0.0332792692981356,0.0299469743724385
CD300E,CMRF35-like molecule 2,Physical measures,X23119.Arm fat percentage (right),51899,0.0838709520935779,0.00773150886007429,0.0687171947278323,0.0990247094593236,2.37119885098929e-27
CD300E,CMRF35-like molecule 2,Physical measures,X23120.Arm fat mass (right),51898,0.0732371692825405,0.00845373137679808,0.0566678557840163,0.0898064827810647,4.87592919918103e-18
CD300E,CMRF35-like molecule 2,Physical measures,X23121.Arm fat-free mass (right),51897,-0.0367442191347755,0.0073239499908508,-0.0510991611168431,-0.0223892771527079,5.28718776808037e-07
CD300E,CMRF35-like molecule 2,Physical measures,X23122.Arm predicted mass (right),51897,-0.0368164562969809,0.00735620429610027,-0.0512346167173374,-0.0223982958766243,5.63223851021193e-07
CD300E,CMRF35-like molecule 2,Physical measures,X23123.Arm fat percentage (left),51895,0.0822299945254673,0.00727916614838799,0.0679628288746268,0.0964971601763077,1.62742392408543e-29
CD300E,CMRF35-like molecule 2,Physical measures,X23124.Arm fat mass (left),51895,0.0678854405252659,0.00812550533170805,0.0519594500751182,0.0838114309754137,6.92678513647472e-17
CD300E,CMRF35-like molecule 2,Physical measures,X23125.Arm fat-free mass (left),51891,-0.0421250941046953,0.00666881858121149,-0.0551959785238698,-0.0290542096855208,2.71993893409394e-10
CD300E,CMRF35-like molecule 2,Physical measures,X23126.Arm predicted mass (left),51890,-0.0420667032306171,0.00670631799229847,-0.0552110864955221,-0.0289223199657121,3.61087102929459e-10
CD300E,CMRF35-like molecule 2,Physical measures,X23127.Trunk fat percentage,51888,0.0673598269149376,0.0058231414221196,0.0559464697275832,0.078773184102292,7.30337649117233e-31
CD300E,CMRF35-like molecule 2,Physical measures,X23128.Trunk fat mass,51888,0.0628246902105435,0.00614176915458803,0.0507868226675509,0.074862557753536,1.65529635292963e-24
CD300E,CMRF35-like molecule 2,Physical measures,X23129.Trunk fat-free mass,51887,-0.0257182170236082,0.00578962081485037,-0.0370658738207149,-0.0143705602265015,8.94850760765628e-06
CD300E,CMRF35-like molecule 2,Physical measures,X23130.Trunk predicted mass,51885,-0.0248280899425631,0.00578564192862608,-0.0361679481226702,-0.0134882317624559,1.78324037827135e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23400.Total Cholesterol,42232,-0.0541309011101413,0.00417943307811827,-0.0623225899432531,-0.0459392122770295,3.85587303072541e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42232,-0.0364049744103753,0.00409678147685338,-0.0444346661050079,-0.0283752827157426,7.10437282481716e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42232,-0.0230968388889117,0.00412819739123282,-0.031188105775728,-0.0150055720020954,2.25004117792881e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23403.VLDL Cholesterol,42232,0.00342127621235447,0.00426429084584061,-0.00493673384549313,0.0117792862702021,0.422388591574973
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42232,-0.0474333555117944,0.0040783998925389,-0.0554270193011706,-0.0394396917224182,4.05041045108684e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23405.LDL Cholesterol,42232,-0.0465034144662061,0.00406087941400522,-0.0544627381176564,-0.0385440908147559,3.17450987501731e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23406.HDL Cholesterol,42232,-0.0925181931756532,0.00458668644423299,-0.10150809860635,-0.0835282877449566,3.50393960288724e-89
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23407.Total Triglycerides,42232,0.0200185635514012,0.00432867712377269,0.0115343563888067,0.0285027707139957,3.78703165247062e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23408.Triglycerides in VLDL,42232,0.0157982732734468,0.00439536983890571,0.00718334838919162,0.024413198157702,0.000326413587838699
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23409.Triglycerides in LDL,42232,0.0313581555229506,0.00407089699992205,0.0233791974031034,0.0393371136427978,1.42042767709516e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23410.Triglycerides in HDL,42232,0.0247023747734972,0.00423486732197191,0.0164020348224322,0.0330027147245621,5.56432897371685e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42232,-0.0496224547111984,0.0042057037230065,-0.0578656340082911,-0.0413792754141056,5.66074212851168e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23412.Phospholipids in VLDL,42232,0.0137918872742964,0.00430682041896147,0.00535051925313189,0.0222332552954609,0.00136630791806015
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23413.Phospholipids in LDL,42232,-0.0432764404346371,0.00407701773167248,-0.0512673951887151,-0.035285485680559,3.22164480366186e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23414.Phospholipids in HDL,42232,-0.0701409750591564,0.00441836261221936,-0.0788009657791063,-0.0614809843392064,3.0165318255837e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23415.Total Esterified Cholesterol,42232,-0.0589755601962483,0.00419689557275426,-0.0672014755188467,-0.05074964487365,1.52748340101116e-44
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42232,0.000283822432418411,0.00424139980085433,-0.00802932117725608,0.0085969660420929,0.946648632676435
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42232,-0.0436961032543687,0.0040629058369538,-0.0516593986947981,-0.0357328078139393,7.20333592959541e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42232,-0.0961387649010428,0.00458484272312291,-0.105125056638364,-0.0871524731637218,4.12958092985402e-96
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23419.Total Free Cholesterol,42232,-0.0414923804002597,0.00413909641511338,-0.0496050093738819,-0.0333797514266375,1.43554462004424e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42232,0.00738631405088359,0.00429157191168652,-0.001025166896022,0.0157977949977892,0.0852515796914445
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23421.Free Cholesterol in LDL,42232,-0.0525637277003041,0.0040754002641703,-0.0605515122180778,-0.0445759431825303,7.70761229723191e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23422.Free Cholesterol in HDL,42232,-0.0728097426750581,0.00458631769029481,-0.0817989253480359,-0.0638205600020803,2.99090080155974e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42232,-0.0363300164800985,0.00404950974605854,-0.0442670555823733,-0.0283929773778238,3.30333074901459e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23424.Total Lipids in VLDL,42232,0.0122683975361396,0.00431075383420143,0.0038193200211048,0.0207174750511744,0.00443385049916794
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23425.Total Lipids in LDL,42232,-0.0421737597074332,0.0040649070806489,-0.0501409775855051,-0.0342065418293614,3.99259058997169e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23426.Total Lipids in HDL,42232,-0.0771826849908232,0.00448338560134212,-0.0859701207694537,-0.0683952492121926,1.00895094303173e-65
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42232,-0.0884918541485974,0.00423393649641144,-0.0967903696815638,-0.080193338615631,1.65255156021069e-95
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23428.Concentration of VLDL Particles,42232,0.0121098597717098,0.00425170711792726,0.00377651382057235,0.0204432057228472,0.00440282699313142
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23429.Concentration of LDL Particles,42232,-0.0214954340273989,0.00410033784508664,-0.0295320962037688,-0.0134587718510291,1.6090632215559e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23430.Concentration of HDL Particles,42232,-0.0909984859374033,0.0042342084270246,-0.0992975344543715,-0.0826994374204351,8.76738577818736e-101
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42232,0.00261864448822243,0.00446664807955238,-0.00613598574770023,0.0113732747241451,0.55770639426633
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42232,-0.0133575320357112,0.00423165321921978,-0.021651572345382,-0.00506349172604041,0.00159981299949943
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42232,-0.0273210567353824,0.00466067912935638,-0.0364559878289209,-0.0181861256418439,4.67807339762481e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23434.Phosphoglycerides,42223,-0.0528646922858923,0.00421391285185848,-0.0611239614755349,-0.0446054230962496,6.66273956528875e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42223,0.0548742533919962,0.00454517613442165,0.0459657081685297,0.0637827986154626,2.16983593114206e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23436.Total Cholines,42223,-0.0571017811610551,0.0042825077051963,-0.0654954962632398,-0.0487080660588703,2.63578642286302e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23437.Phosphatidylcholines,42223,-0.0603183835979471,0.00429584933996326,-0.0687382483042751,-0.0518985188916191,1.78350977347643e-44
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23438.Sphingomyelins,42223,-0.0463703769276187,0.004331529046573,-0.0548601738589017,-0.0378805799963356,1.22644847395005e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23439.Apolipoprotein B,42232,-0.0191446331117282,0.00411498609108227,-0.0272100058502494,-0.0110792603732069,3.31152153738832e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23440.Apolipoprotein A1,42232,-0.0815431204693202,0.00437995206470017,-0.0901278265161326,-0.0729584144225079,2.05412977532368e-76
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42232,0.0255667799250763,0.00420275503551031,0.0173293800554761,0.0338041797946765,1.20855892283333e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23442.Total Fatty Acids,42223,-0.00907815475593619,0.00395758464631303,-0.0168350206627097,-0.00132128884916264,0.0218135489538798
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23443.Degree of Unsaturation,42223,-0.0700609601487457,0.00425127921078579,-0.0783934674018858,-0.0617284528956055,1.96309968845063e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42223,-0.0555010497955776,0.00413470553680852,-0.0636050726477223,-0.0473970269434329,8.03253349047336e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42223,-0.0279023095189544,0.00409154595169851,-0.0359217395842835,-0.0198828794536254,9.52069195822856e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42223,-0.0378284023912086,0.00410322947466491,-0.0458707321615518,-0.0297860726208654,3.42697361708746e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42223,0.0208034207865679,0.00403095852556073,0.0129027420764689,0.028704099496667,2.49205999640341e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23448.Saturated Fatty Acids,42223,-0.0103725337092205,0.00390349028726966,-0.018023374672269,-0.00272169274617194,0.00788738367787513
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23449.Linoleic Acid,42223,-0.0173601177986698,0.00408987279936427,-0.0253762684854238,-0.00934396711191586,2.2037523283523e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23450.Docosahexaenoic Acid,42223,-0.0748993824593071,0.00408105195477367,-0.0828982442906635,-0.0669005206279507,2.45408130239769e-74
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42223,-0.0625385029395489,0.0041436185558272,-0.0706599953089702,-0.0544170105701275,4.67534555840695e-51
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42223,-0.0232982649999394,0.00409730732304164,-0.031328987353101,-0.0152675426467778,1.32534958012901e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42223,-0.0474028161487404,0.00418164929232181,-0.0555988487616912,-0.0392067835357897,1.1828338371809e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42223,0.0810244153912605,0.00436045008674181,0.0724779332212465,0.0895708975612744,3.93742856511322e-76
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42223,-0.00891959165849847,0.00382048018311379,-0.0164077328174015,-0.00143145049959544,0.0195746903815801
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42223,-0.0137708471926611,0.00420670814986667,-0.0220159951663998,-0.0055256992189224,0.0010647229153611
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42223,-0.0688565148688231,0.00405039521462199,-0.0767952894894822,-0.060917740248164,3.76486423258291e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42223,-0.068924527247074,0.00433129467481493,-0.0774138648097113,-0.0604351896844367,1.65761212519649e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42223,0.0502900077578681,0.00410111493506703,0.0422518224851368,0.0583281930305995,2.18515144052927e-34
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23460.Alanine,42229,-0.0113036816041284,0.00412358543064894,-0.0193859090482004,-0.00322145416005652,0.00612900847078378
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23461.Glutamine,42196,-0.0197108815625672,0.00404903282256231,-0.0276469858947894,-0.0117747772303451,1.13972757832555e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23462.Glycine,42218,0.011619919715115,0.00490529286279824,0.00200554570403046,0.0212342937261996,0.0178571962928411
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23463.Histidine,42215,-0.03565674983638,0.00406905071032077,-0.0436320892286088,-0.0276814104441513,2.12527486253887e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42221,-0.0310805491207686,0.00457084071118223,-0.0400393969146857,-0.0221217013268514,1.09172321689024e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23465.Isoleucine,42230,-0.0109725658490415,0.00441817290372513,-0.0196321847403428,-0.00231294695774028,0.0130214855136523
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23466.Leucine,42230,-0.0308831293053752,0.00453366688048614,-0.039769116391128,-0.0219971422196224,1.00320496710388e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23467.Valine,42221,-0.0350010858097315,0.00453703608034833,-0.0438936765272142,-0.0261084950922488,1.29844555228785e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23468.Phenylalanine,42224,0.032813653406869,0.00418974184927922,0.0246017593822817,0.0410255474314563,5.15930337827078e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23469.Tyrosine,42218,-0.0107698508031709,0.00435590627494157,-0.0193074271020563,-0.00223227450428537,0.0134303921149465
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23470.Glucose,42210,-0.023522449471811,0.00396222555072745,-0.0312884115512368,-0.0157564873923852,2.97940231976263e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23471.Lactate,42212,0.0286105680154068,0.00417319033043619,0.0204311149677519,0.0367900210630617,7.39691444609561e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23472.Pyruvate,42193,0.0305784663754066,0.00400794167134534,0.0227229006995698,0.0384340320512435,2.51367448160525e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23473.Citrate,42230,0.0285309942037099,0.00415350001860219,0.0203901341672496,0.0366718542401701,6.73889365516476e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23474.3-Hydroxybutyrate,41951,0.0456122034522036,0.00457775407880612,0.0366398054577436,0.0545846014466636,2.64515593334058e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23475.Acetate,42221,-0.0306899556470549,0.00396355311788692,-0.0384585197581133,-0.0229213915359966,1.03892577423591e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23476.Acetoacetate,42231,0.0064954749097382,0.00417154445573077,-0.00168075222349411,0.0146717020429705,0.119472064141196
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23477.Acetone,42231,-0.011307346682732,0.0041428946137468,-0.0194274201256758,-0.0031872732397883,0.00635436528269952
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23478.Creatinine,41976,0.151948466314739,0.00481092875251282,0.142519045959813,0.161377886669664,3.15714971467713e-211
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23479.Albumin,42230,-0.0923320348366987,0.00404695397761953,-0.100264064632833,-0.0844000050405645,4.20386027033021e-113
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23480.Glycoprotein Acetyls,42232,0.104503815171444,0.00418989010060083,0.0962916305742659,0.112715999768621,2.62265212651709e-134
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42232,0.0304435238485968,0.00435382895473381,0.0219100190973185,0.0389770285998751,2.82893055027129e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42232,0.0275575770279696,0.0043301737220376,0.0190704365327759,0.0360447175231633,2.02747620149758e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42232,0.0339719236951667,0.00447092939639952,0.0252089020782236,0.0427349453121097,3.19321043762818e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42232,0.031526819150736,0.0043991471665909,0.0229044907042178,0.0401491475972542,8.08493615650825e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42232,0.0301835720603599,0.00440045449246479,0.021558681255129,0.0388084628655909,7.22355646260846e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42232,0.031895874573439,0.00436944723452145,0.023331757993777,0.0404599911531011,3.0425935393709e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42232,0.0234264105687084,0.0042485089531281,0.0150993330205773,0.0317534881168394,3.57086323631475e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42232,0.0194479322566618,0.00453759944314565,0.0105542373480964,0.0283416271652273,1.83207962019244e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42232,0.017163919949457,0.00450590443879185,0.00833234724942497,0.025995492649489,0.00014002534348015
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42232,0.021521486236121,0.00450331904591826,0.0126949809061212,0.0303479915661208,1.7798270100363e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42232,0.016302743879319,0.00447866942538736,0.00752455180555978,0.0250809359530782,0.000273554688517302
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42232,0.0116760360684418,0.00447486761739901,0.00290529553833978,0.0204467765985439,0.00908407573256756
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42232,0.0206079511332018,0.00446619212491633,0.0118542145683658,0.0293616876980378,3.98188012996516e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42232,0.0159243941920158,0.00451786615622865,0.00706937652580763,0.0247794118582239,0.000425256360255746
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42232,0.0146799085201427,0.00447277628570453,0.00591326700016182,0.0234465500401236,0.00103311773046745
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42232,0.00896706459181557,0.00446108158418279,0.000223344686817298,0.0177107844968138,0.0444439579184757
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42232,0.0187367104605022,0.00454639153288296,0.00982578305605161,0.0276476378649528,3.79088869373658e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42232,0.0141432817902576,0.00449524547802269,0.00533260065333309,0.022953962927182,0.00165719833740284
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42232,0.0129021199579282,0.00446405873725496,0.00415256483290853,0.021651675082948,0.00385577487182054
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42232,0.0148611393052229,0.00453493411660025,0.00597266843668644,0.0237496101737594,0.001051655552122
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42232,0.00178500908162458,0.00439887767201691,-0.00683679115552857,0.0104068093187777,0.684905194916966
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42232,-0.00897776851566292,0.00421455668337147,-0.017238299615071,-0.000717237416254847,0.0331745286357873
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42232,-0.00727937089117046,0.00422680206250714,-0.0155639029336845,0.00100516115134353,0.085057161261522
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42232,-0.00921080473646583,0.00420382460024145,-0.0174503009529391,-0.000971308519992579,0.0284647853942876
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42232,-0.020579645534415,0.00412692782997928,-0.0286684240811743,-0.0124908669876556,6.21829388667832e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42232,-0.0251817245829981,0.00411342805206944,-0.0332440435650542,-0.017119405600942,9.50423634590846e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42232,-0.0130134310806198,0.0041810963493336,-0.0212083799253137,-0.00481848223592595,0.00185928464950383
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42232,0.0023055497263811,0.00434366130592977,-0.00620802643324124,0.0108191258860034,0.59557650864024
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42232,0.0206021538018518,0.0043493079777523,0.0120775101654573,0.0291267974382463,2.19220854714152e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42232,0.0151225251591391,0.00435413013379915,0.00658843009689276,0.0236566202213854,0.000515993723469052
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42232,0.000431853027576578,0.0042695062535109,-0.00793637922930479,0.00880008528445794,0.919434274859176
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42232,0.003397507223065,0.00430706895320509,-0.00504434792521698,0.011839362371347,0.430230245357576
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42232,0.0120656377606425,0.00438307961393772,0.00347480171732457,0.0206564738039604,0.00591704374851873
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42232,-0.0106000208821856,0.00418749237102779,-0.0188075059294001,-0.00239253583497117,0.0113734905668618
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42232,0.0296643703766538,0.00438767226151803,0.0210645327440785,0.0382642080092291,1.42772571822786e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42232,0.0164189263743106,0.00416001682107753,0.0082652934049986,0.0245725593436225,7.95863987312927e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42232,0.0181461608775134,0.00418982193102898,0.00993410989269662,0.0263582118623302,1.49487703457487e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42232,0.0298454348360758,0.00417210680669316,0.0216681054949572,0.0380227641771944,8.8867143570801e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42232,-0.00424658040901681,0.00421624645269618,-0.0125104234563013,0.00401726263826771,0.313859173205808
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42232,-0.0123988196051216,0.00424403894228034,-0.020717135931991,-0.0040805032782521,0.00348958791520256
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42232,0.0145771593388789,0.00418059671237112,0.00638318978263151,0.0227711288951263,0.000490264519530036
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42232,0.0472102086399856,0.00424724318996718,0.0388856119876499,0.0555348052923213,1.39930967543116e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23523.Concentration of IDL Particles,42232,-0.024517451129495,0.00411582159926986,-0.0325844614640639,-0.0164504407949261,2.63434198384467e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23524.Total Lipids in IDL,42232,-0.0399926475070124,0.00419576651368138,-0.0482163498738279,-0.0317689451401969,1.80549274850808e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23525.Phospholipids in IDL,42232,-0.0294183794439279,0.00420156122767505,-0.037653439450171,-0.0211833194376848,2.64574504910491e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23526.Cholesterol in IDL,42232,-0.0500811801259881,0.00420849669017637,-0.0583298336387337,-0.0418325266132424,1.71367824749161e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42232,-0.0531042062463995,0.00421129728114585,-0.0613583489174453,-0.0448500635753536,2.96596124713084e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23528.Free Cholesterol in IDL,42232,-0.0401209242345482,0.00418683650048426,-0.0483271237754973,-0.031914724693599,1.10714014953966e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23529.Triglycerides in IDL,42232,0.0414399645592248,0.00410646303951707,0.0333912970017713,0.0494886321166782,7.31366136532375e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42232,-0.0204909793903354,0.00408406920438755,-0.028495755030935,-0.0124862037497358,5.30641080976416e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23531.Total Lipids in Large LDL,42232,-0.0464400139778193,0.00408091939710096,-0.0544386159961372,-0.0384414119595014,7.19105826678977e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23532.Phospholipids in Large LDL,42232,-0.0487100359982891,0.00409086618819746,-0.0567281337271561,-0.0406919382694221,1.57700729980159e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23533.Cholesterol in Large LDL,42232,-0.0503805941552876,0.00407957075078491,-0.058376552826826,-0.0423846354837492,7.52843322149613e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42232,-0.0486863460576817,0.00407537500507955,-0.0566740810676376,-0.0406986110477258,9.86765598249029e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42232,-0.0540513654170794,0.00411023412737785,-0.06210742430674,-0.0459953065274188,2.93307296825755e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23536.Triglycerides in Large LDL,42232,0.0317156554809553,0.00406433143226437,0.0237495658737171,0.0396817450881935,6.46248597514234e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42232,-0.0259784926988944,0.00412281100347369,-0.0340592022657029,-0.017897783132086,3.04512342296688e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42232,-0.0371521178068282,0.00408895877145035,-0.0451664769988709,-0.0291377586147855,1.16762992895426e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42232,-0.0392359421405643,0.00410276127436903,-0.0472773542383276,-0.031194530042801,1.33320483962955e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42232,-0.0406116768924334,0.00408095236964068,-0.0486103435369292,-0.0326130102479377,2.98116306479478e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42232,-0.035775774123092,0.00410056565341072,-0.0438128828037771,-0.027738665442407,2.97789423279494e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42232,-0.0510789698165892,0.00405121947139817,-0.0590193599805296,-0.0431385796526488,3.02779079231541e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42232,0.029660643323634,0.00409371769450578,0.0216369566424026,0.0376843300048653,4.54304780980095e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42232,-0.014058054369928,0.00413086574530518,-0.0221545512307262,-0.00596155750912986,0.000667994874565916
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23545.Total Lipids in Small LDL,42232,-0.02754085408434,0.00406663562210564,-0.035511459903667,-0.0195702482650129,1.31859698425059e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23546.Phospholipids in Small LDL,42232,-0.0236636088234307,0.0040563600229644,-0.0316140744684409,-0.0157131431784205,5.54398857124088e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23547.Cholesterol in Small LDL,42232,-0.0341455213606202,0.00407459291489365,-0.0421317234738117,-0.0261593192474286,5.80155804077765e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42232,-0.0285149413849872,0.00408039435371007,-0.036512514318259,-0.0205173684517155,2.91201806187955e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42232,-0.0448780163463046,0.00406463506559513,-0.052844701074871,-0.0369113316177381,3.18805463354573e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23550.Triglycerides in Small LDL,42232,0.0307520178458463,0.00414718179134251,0.022623541534815,0.0388804941568777,1.28640844238681e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42232,-0.00435631499752087,0.00475520601783509,-0.0136765187924776,0.0049638887974359,0.359622848832828
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42232,-0.000580961849483128,0.00477213142041427,-0.0099343394334951,0.00877241573452884,0.90310630123915
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42232,0.00496621651594683,0.00474796504685633,-0.00433979497589158,0.0142722280077852,0.295594643366755
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42232,-0.013177054024422,0.00482496044718066,-0.0226339765008961,-0.00372013154794793,0.00632202012147862
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42232,-0.0219390814759327,0.00484617385900612,-0.0314375822395847,-0.0124405807122807,6.0306974532972e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42232,0.0152638440032407,0.00469363714008327,0.00606431520867746,0.0244633727978039,0.0011486285403645
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42232,0.0365898207203953,0.00395763901854851,0.0288328482440402,0.0443467931967504,2.68736274204309e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42232,-0.054506699330086,0.00476835076790527,-0.0638526668351804,-0.0451607318249917,4.01763034410475e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23559.Total Lipids in Large HDL,42232,-0.0531217636781074,0.00472772094252228,-0.0623880967254511,-0.0438554306307638,3.6362203338242e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23560.Phospholipids in Large HDL,42232,-0.0523882987750511,0.00468209746363527,-0.0615652098037762,-0.0432113877463259,6.16602844755577e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23561.Cholesterol in Large HDL,42232,-0.0575493861301359,0.00479654763058965,-0.0669506194860916,-0.0481481527741802,5.33099271654437e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42232,-0.0606277450619942,0.00481041030611968,-0.0700561492619887,-0.0511993408619996,3.21759097669909e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42232,-0.0450500786980165,0.0047509284864181,-0.054361898531396,-0.035738258864637,2.89046841289086e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23564.Triglycerides in Large HDL,42232,0.0226753086427269,0.00417385957269722,0.0144945438802404,0.0308560734052135,5.64618385476626e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42232,-0.0811946878848167,0.00433201301486267,-0.0896854333939476,-0.0727039423756859,2.07176390327847e-77
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42232,-0.0763831364646178,0.00426506217546968,-0.0847426583285383,-0.0680236146006972,6.49943403552863e-71
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42232,-0.0687819957130331,0.00420054104161043,-0.0770150561545895,-0.0605489352714767,1.07829060169206e-59
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42232,-0.0910584596869147,0.0043691495108636,-0.0996219927282073,-0.082494926645622,5.50663177663689e-95
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42232,-0.0924418268427978,0.00436112002789508,-0.100989622097472,-0.0838940315881235,3.88903889836707e-98
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42232,-0.0817517222510501,0.00440227437197685,-0.0903801800201247,-0.0731232644819755,4.83026973335468e-76
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42232,0.0168712843485126,0.00428463173491706,0.00847340614807511,0.02526916254895,8.27004938751965e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42232,-0.0849357377288031,0.0040450888196139,-0.0928641118152464,-0.0770073636423599,2.3142983888589e-96
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23573.Total Lipids in Small HDL,42232,-0.0733395438466925,0.00405775418030626,-0.0812927420400928,-0.0653863456532923,3.55215979406596e-72
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23574.Phospholipids in Small HDL,42232,-0.0692642745143168,0.0040407851884425,-0.0771842134836641,-0.0613443355449695,3.51475976065326e-65
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23575.Cholesterol in Small HDL,42232,-0.0890714558818717,0.00401757621340659,-0.0969459052601486,-0.0811970065035948,5.10612021804663e-107
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42232,-0.0934156677624978,0.00403661758298651,-0.101327438225151,-0.0855038972998442,2.99946008323379e-116
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42232,-0.0653571856279724,0.004034854238914,-0.0732654999362438,-0.0574488713197009,1.82479943323072e-58
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23578.Triglycerides in Small HDL,42232,0.0308039706568091,0.00460658635588343,0.0217750613992775,0.0398328799143406,2.36759840504461e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41849,0.0454194258875979,0.00461542136275375,0.0363732000166006,0.0544656517585953,8.99023505819515e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41849,0.000399229045863838,0.00445037615815952,-0.00832350822412882,0.00912196631585649,0.928521560603571
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41849,-0.00109881703355766,0.00450757092436103,-0.00993365604530529,0.00773602197818996,0.807411618778336
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41849,0.00276463331644006,0.0044461581689179,-0.00594983669463902,0.0114791033275191,0.53408228587302
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41849,-0.0113802085927461,0.00450407666317922,-0.0202081988525774,-0.00255221833291488,0.0115272858028808
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42157,0.0414031821121411,0.00452814759538204,0.0325280128251923,0.0502783513990899,6.89460188499299e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42157,-0.0127197166590133,0.00458190304996438,-0.0217002466369435,-0.00373918668108309,0.00550945918401352
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42157,-0.0194766304392132,0.00455156388627073,-0.0283976956563038,-0.0105555652221225,1.8893213883412e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42157,0.0165855561068261,0.00459480300234882,0.00757974222222241,0.0255913699914298,0.000307734760359355
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42157,0.00123861496554831,0.00456904538679745,-0.0077167139925747,0.0101939439236713,0.78632721042036
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42232,0.0742373030166559,0.00469828375233478,0.0650286668620798,0.0834459391712321,9.56907064106978e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42232,0.0151824484393261,0.00443176372105974,0.00649619154604904,0.0238687053326032,0.0006147416795453
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42232,0.00636556564003701,0.00450623776366777,-0.00246666037675182,0.0151977916568258,0.157792661356159
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42232,0.0401715730645193,0.00448387664430882,0.031383174841674,0.0489599712873646,3.69243589273909e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42232,-0.0407735459688417,0.00450674845372826,-0.049606772938149,-0.0319403189995343,1.66239837635959e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42232,-0.0131888143096737,0.00434669018676489,-0.0217083270757329,-0.00466930154361455,0.00241612752531497
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42232,-0.0281068754058626,0.00449243023550145,-0.0369120386674454,-0.0193017121442797,4.05494658389275e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42232,-0.030638596738061,0.0045201024958624,-0.0394979976299513,-0.0217791958461706,1.26600539245755e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42232,-0.0198901815729689,0.00439943819945932,-0.0285130804439091,-0.0112672827020286,6.2045356251111e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42232,0.0247988653051461,0.00445630338075954,0.0160645106788574,0.0335332199314348,2.67254930510957e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42232,-0.0539160953786036,0.00435760974465732,-0.0624570104781319,-0.0453751802790752,5.64680620758361e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42232,-0.0271341145558617,0.00422714843529067,-0.0354193254890314,-0.018848903622692,1.41702419161123e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42232,-0.00533272998724514,0.00417166966112717,-0.0135092025230544,0.0028437425485641,0.201158279388515
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42232,-0.0550523566652471,0.00439442984119239,-0.0636654391539841,-0.04643927417651,8.28690364838687e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42232,0.0354279484519648,0.00426469693449931,0.0270691424603462,0.0437867544435835,1.07112165542562e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42232,0.0973895505427135,0.00406667959808946,0.0894188585304581,0.105360242554969,3.48441638177087e-124
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42232,-0.0618064043695407,0.00433739613666713,-0.0703077007974083,-0.0533051079416731,9.5951106145995e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42232,-0.0671923440232836,0.00439094630197535,-0.0757985987751553,-0.0585860892714119,2.00623992119433e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42232,-0.0139013198743349,0.00386193251267443,-0.0214707075991768,-0.00633193214949302,0.00031986695224499
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42232,0.0461400834128007,0.00429775316227289,0.0377164872147458,0.0545636796108555,8.83759309002191e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42232,0.0789259808822771,0.00399666413192132,0.0710925191837113,0.0867594425808429,1.30792003796407e-85
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42232,-0.0877335089403449,0.00417939610067203,-0.0959251252976621,-0.0795418925830277,2.58034581459293e-96
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42232,-0.0948441365593425,0.0041077885809568,-0.102895402178018,-0.0867928709406671,9.81801068607027e-116
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42232,-0.0172357662185093,0.00390070654997408,-0.0248811510564585,-0.00959038138056008,1.000965099423e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42232,0.0788954037032737,0.00422245739493496,0.0706193872092011,0.0871714201973462,6.01283215617738e-77
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42232,-0.00407600309748718,0.0041543165690454,-0.0122184635728162,0.0040664573778418,0.326536735370625
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42232,-0.0832879237271535,0.00417092335351863,-0.09146293350005,-0.075112913954257,1.82692388798353e-87
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42232,-0.0564182387265245,0.00402101083713941,-0.0642994199673178,-0.0485370574857313,2.05504669110708e-44
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42232,-0.0604964926070827,0.00450273866338296,-0.0693218603873133,-0.0516711248268521,6.81805229447122e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42232,0.0825390217352191,0.00410399476459931,0.0744951919966044,0.0905828514738337,1.11764958156991e-88
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42232,-0.00481794294587243,0.00426919075637389,-0.0131855568283652,0.00354967093662039,0.259112742159034
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42232,-0.0703437202126658,0.00417316004619263,-0.0785231139032034,-0.0621643265221282,4.10950728414292e-63
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42232,-0.011965055996572,0.00426684953390475,-0.0203280810830253,-0.00360203091011866,0.0050514540958477
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42232,-0.0539391712218211,0.00435686191701728,-0.062478620579175,-0.0453997218644672,5.15356740571718e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42232,0.0785472459497368,0.00409832030936516,0.0705145381433811,0.0865799537560925,8.24488047846291e-81
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42232,0.0259752334784461,0.00424372169495108,0.0176575389563419,0.0342929280005502,9.56227314475305e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42232,-0.069646893722225,0.00409654342418049,-0.0776761188336188,-0.0616176686108313,3.67230114505086e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42232,-0.0212243784436564,0.00420859127570096,-0.0294732173440303,-0.0129755395432825,4.63916232682803e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42232,-0.0552978902364665,0.0041398679877479,-0.0634120314924524,-0.0471837489804806,1.92540231148486e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42232,0.0621013047863999,0.00420671506378613,0.0538561432613791,0.0703464663114208,6.10692458999517e-49
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42220,0.0194253088956928,0.00452087155400308,0.0105644006498468,0.0282862171415388,1.74479041834452e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42220,-0.0380203686875837,0.0039171240732561,-0.0456979318711657,-0.0303428055040018,3.34832114351959e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42220,-0.0668576906581041,0.00361751446734978,-0.0739480190141096,-0.0597673623020985,2.4137974408179e-75
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42220,0.0223068150977015,0.00468391484088798,0.0131263420095611,0.0314872881858419,1.93246561337045e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42220,0.0320490223180753,0.00440544267387124,0.0234143546772877,0.0406836899588629,3.65702155032777e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42232,0.0115596849568878,0.00417191802386194,0.00338272563011838,0.0197366442836572,0.00559889640353444
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42232,-0.0455885154231125,0.00438746188316599,-0.0541879407141178,-0.0369890901321071,3.39669031041226e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42232,-0.0490892231218315,0.00421778918399993,-0.0573560899224714,-0.0408223563211917,3.68144617289436e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42232,-0.000842130273734614,0.00421437676869812,-0.00910230874038293,0.0074180481929137,0.841621832759629
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42232,0.0611650964854993,0.00419475461833719,0.0529433774335584,0.0693868155374402,8.45327531039835e-48
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42232,0.0781052606963548,0.00446816272721307,0.0693476617510172,0.0868628596416924,1.10424070349337e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42232,-0.0799646653690422,0.00445375669691935,-0.0886940284950042,-0.0712353022430803,2.92691241880055e-71
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42232,-0.0669768561037465,0.00424450564535869,-0.0752960871686495,-0.0586576250388435,1.33276600703695e-55
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42232,-0.0777605558516662,0.00464498154051704,-0.0868647196710796,-0.0686563920322528,2.76644727804455e-62
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42232,0.0742093490984207,0.004393412177999,0.0655982612295427,0.0828204369672988,2.30633400248626e-63
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42232,0.0127987067756981,0.00412837808088067,0.00470708573717203,0.0208903278142243,0.00193798570806039
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42232,-0.055401545995925,0.00406421286270732,-0.0633674032068313,-0.0474356887850186,4.90232117928039e-42
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42232,-0.0572907322166806,0.00400480261289117,-0.0651401453379473,-0.0494413190954139,4.35694829280767e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42232,0.00811572585130908,0.00437167428122117,-0.000452755739884425,0.0166842074425026,0.0634132468978687
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42232,0.0815585000537946,0.00456619956904488,0.0726087488984666,0.0905082512091226,1.49919766816775e-70
CD300E,CMRF35-like molecule 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52100,-0.00391323452690804,0.00345752202237478,-0.0106899776907626,0.00286350863694653,0.257728726329983
CD300E,CMRF35-like molecule 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52100,-0.00390109987250314,0.00335872879874832,-0.0104842083180498,0.00268200857304356,0.245458119642
CD300E,CMRF35-like molecule 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50543,-0.00255345601083706,0.00320934982731367,-0.00884378167237185,0.00373686965069774,0.42625554808816
CD300E,CMRF35-like molecule 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50543,-0.00335717693217851,0.00349494179679997,-0.0102072628539065,0.00349290898954944,0.336773146826088
CD300E,CMRF35-like molecule 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50543,-0.00547325782093795,0.0034589687025491,-0.0122528364779342,0.00130632083605828,0.11358682900248
CD300E,CMRF35-like molecule 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50543,-0.00542877501536352,0.00318198069727401,-0.0116654571820206,0.00080790715129355,0.0880037452409603
CD300E,CMRF35-like molecule 2,Working and living environment,X24009.Traffic intensity on the nearest road,52100,-0.157261306968942,0.0580450844628508,-0.27102967251613,-0.0434929414217545,0.00674750512058828
CD300E,CMRF35-like molecule 2,Working and living environment,X24010.Inverse distance to the nearest road,52100,0.00286189354744554,0.00302162667770156,-0.00306049474084951,0.00878428183574059,0.343578860011213
CD300E,CMRF35-like molecule 2,Working and living environment,X24011.Traffic intensity on the nearest major road,52100,0.00202218251001702,0.00301152023395694,-0.00388039714853859,0.00792476216857262,0.501919936753995
CD300E,CMRF35-like molecule 2,Working and living environment,X24012.Inverse distance to the nearest major road,52100,-0.0082266057486525,0.00305446586285612,-0.0142133588398505,-0.0022398526574545,0.00707978809468115
CD300E,CMRF35-like molecule 2,Working and living environment,X24013.Total traffic load on major roads,52100,-0.0827056916312861,0.0400489629321627,-0.161201658978325,-0.00420972428424719,0.0389231154142287
CD300E,CMRF35-like molecule 2,Working and living environment,X24015.Sum of road length of major roads within 100m,52100,-0.10078596467583,0.0390071866059922,-0.177240050423574,-0.0243318789280852,0.00977840696742166
CD300E,CMRF35-like molecule 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52100,-0.003331665345588,0.00346931002561367,-0.0101315129957908,0.00346818230461479,0.336901523647333
CD300E,CMRF35-like molecule 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52100,-0.0034380733375112,0.00346917493632627,-0.0102376562127107,0.00336150953768829,0.321678756680211
CD300E,CMRF35-like molecule 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52100,-0.00184710096135805,0.00342801638181527,-0.00856601306971597,0.00487181114699988,0.590012708782967
CD300E,CMRF35-like molecule 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52063,0.000547148918767971,0.00335327944665385,-0.00602527879667358,0.00711957663420952,0.870387327061877
CD300E,CMRF35-like molecule 2,Working and living environment,X24020.Average daytime sound level of noise pollution,52100,-0.00502049653592097,0.00301978860821439,-0.0109392822080212,0.000898289136179232,0.0964193999453256
CD300E,CMRF35-like molecule 2,Working and living environment,X24021.Average evening sound level of noise pollution,52100,-0.00500838499065099,0.00301973258296767,-0.0109270608532676,0.000910290871965646,0.0972193479042875
CD300E,CMRF35-like molecule 2,Working and living environment,X24022.Average night-time sound level of noise pollution,52100,-0.00503293504376439,0.00301990565303529,-0.0109519501237136,0.00088608003618477,0.0956099123382401
CD300E,CMRF35-like molecule 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52100,-0.00497616206095656,0.0030197975011986,-0.0108949651633058,0.000942641041392696,0.0993975893452751
CD300E,CMRF35-like molecule 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52100,-0.00497014164867352,0.00301984792490986,-0.0108890435814968,0.000948760284149808,0.0998131366912115
CD300E,CMRF35-like molecule 2,Health and medical history,X2405.Number of children fathered,52090,-0.104606229373311,0.0302600055671709,-0.163915840284966,-0.0452966184616565,0.000547366325022513
CD300E,CMRF35-like molecule 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49571,0.00340051157142543,0.00356477649821298,-0.00358645036507202,0.0103874735079229,0.340135137574337
CD300E,CMRF35-like molecule 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49571,0.00712867125537644,0.00320334598605766,0.000850113122703429,0.0134072293880494,0.0260661394465308
CD300E,CMRF35-like molecule 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49571,-0.001938569751191,0.00323552563226555,-0.00828019999043148,0.00440306048804949,0.549078392474383
CD300E,CMRF35-like molecule 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49571,0.000537031185156591,0.00334748399564408,-0.0060240374463058,0.00709809981661898,0.872545239012506
CD300E,CMRF35-like molecule 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49571,0.00667510241977939,0.00323352920296049,0.000337385181976836,0.0130128196575819,0.0389977962705856
CD300E,CMRF35-like molecule 2,Working and living environment,"X24505.Water percentage, buffer 300m",49571,-0.000871320764255117,0.00325376323029181,-0.00724869669562706,0.00550605516711682,0.78886466471347
CD300E,CMRF35-like molecule 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52181,0.00180289058375483,0.00342743789150791,-0.00491488768360067,0.00852066885111033,0.598881344895486
CD300E,CMRF35-like molecule 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52181,0.00121318613880979,0.00320748772896134,-0.00507348980995443,0.00749986208757401,0.705258964599135
CD300E,CMRF35-like molecule 2,Working and living environment,X24508.Distance (Euclidean) to coast,52181,0.00493487883687565,0.0030310633589415,-0.00100600534664969,0.010875763020401,0.103516722245467
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2867.Age started smoking in former smokers,35546,-0.0185370836845103,0.00572360382804816,-0.0297553471874847,-0.00731882018153589,0.00120636817344719
CD300E,CMRF35-like molecule 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",37079,-0.0103996361455005,0.0646882013570401,-0.137188510805299,0.116389238514298,0.872281867360493
CD300E,CMRF35-like molecule 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,37078,0.115540705168361,0.0732879911174016,-0.0281037574217461,0.259185167758468,0.11494106597614
CD300E,CMRF35-like molecule 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,37078,0.134447301727617,0.0682158558158299,0.000744224328590309,0.268150379126643,0.0487666745336971
CD300E,CMRF35-like molecule 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",37067,0.110838178496797,0.0684799194717482,-0.023382463667829,0.245058820661424,0.105581360344722
CD300E,CMRF35-like molecule 2,Mental health,X28739.Difficulty with standing for long periods,37086,0.366970282992622,0.0587356868579961,0.251848336750949,0.482092229234294,4.36254260505021e-10
CD300E,CMRF35-like molecule 2,Mental health,X28740.Difficulty with taking care of household responsibilities,37103,0.308546041754685,0.0680818252491211,0.175105664266408,0.441986419242962,5.92295532271915e-06
CD300E,CMRF35-like molecule 2,Mental health,X28741.Difficulty learning a new task,37056,0.0390690165480939,0.0807716276696445,-0.119243373684409,0.197381406780597,0.628613253833409
CD300E,CMRF35-like molecule 2,Mental health,X28742.Difficulty with joining in community activities,36628,0.07015313695887,0.0735228734422754,-0.0739516949879899,0.21425796890573,0.340027598206497
CD300E,CMRF35-like molecule 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,37048,0.165897565073435,0.0644619642650448,0.0395521151139468,0.292243015032922,0.0100823433968881
CD300E,CMRF35-like molecule 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,37109,0.0889692616261795,0.086265759757603,-0.0801116274987224,0.258050150751081,0.302411094232872
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34943,0.115329344942329,0.0555036536650452,0.00654218375884032,0.224116506125817,0.0377615189308237
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2897.Age stopped smoking,35541,0.0373142943604316,0.00600442360560125,0.0255456240934532,0.0490829646274101,5.44797472272491e-10
CD300E,CMRF35-like molecule 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36131,0.00430215200975429,0.0109102766040854,-0.017081990134253,0.0256862941537616,0.693355170177628
CD300E,CMRF35-like molecule 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36131,0.00748041556513595,0.0123465122761722,-0.0167187484961616,0.0316795796264335,0.544617503295654
CD300E,CMRF35-like molecule 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36131,0.00718984003295558,0.0409675061850971,-0.0731064720898347,0.0874861521557458,0.860690670217081
CD300E,CMRF35-like molecule 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36131,-0.0370159598875188,0.0405854842731489,-0.116563509062891,0.042531589287853,0.361771993608207
CD300E,CMRF35-like molecule 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36131,-0.0550922170919061,0.0506081016825511,-0.154284096389706,0.0440996622058941,0.276363080329804
CD300E,CMRF35-like molecule 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36131,-0.0527231873053152,0.0449632395400796,-0.140851136803871,0.0354047621932408,0.240999650251107
CD300E,CMRF35-like molecule 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36131,-0.0232628206555454,0.0184933487970366,-0.0595097842977371,0.0129841429866463,0.208466196783353
CD300E,CMRF35-like molecule 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36131,-0.0164996407191828,0.0347768685555119,-0.0846623030879862,0.0516630216496206,0.635197814951095
CD300E,CMRF35-like molecule 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,36083,0.181239262357491,0.069963945821506,0.0441099285473395,0.318368596167643,0.00960318772895165
CD300E,CMRF35-like molecule 2,Mental health,X29003.Recent feelings of depression,36084,0.177455975940354,0.0692946572691628,0.0416384476927947,0.313273504187913,0.0104598911787225
CD300E,CMRF35-like molecule 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",36088,0.083594815998179,0.0548367224755455,-0.0238851600538902,0.191074792050248,0.127443249117449
CD300E,CMRF35-like molecule 2,Mental health,X29005.Recent feelings of tiredness or low energy,36090,0.206006213043102,0.0541374506931589,0.0998968096845101,0.312115616401693,0.000142793129726635
CD300E,CMRF35-like molecule 2,Mental health,X29006.Recent poor appetite or overeating,36096,0.21192343332634,0.0843233629121092,0.0466496420186056,0.377197224634073,0.011984171148792
CD300E,CMRF35-like molecule 2,Mental health,X29007.Recent feelings of inadequacy,36071,0.0790337823311974,0.0758655659799828,-0.0696627269895689,0.227730291651964,0.297556252309623
CD300E,CMRF35-like molecule 2,Mental health,X29008.Recent trouble concentrating on things,36091,0.072583786569574,0.0724739907820662,-0.0694652353632757,0.214632808502424,0.316610265318242
CD300E,CMRF35-like molecule 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,36089,0.200857227816489,0.121629390731487,-0.0375363780172259,0.439250833650204,0.0987014599345401
CD300E,CMRF35-like molecule 2,Mental health,X29010.Recent thoughts of suicide or self-harm,36068,0.267573220625928,0.131564213345683,0.00970736246838977,0.525439078783467,0.0420086420619484
CD300E,CMRF35-like molecule 2,Mental health,X29038#0.Substances taken for depression_None of options listed,36013,-0.0434707585178656,0.0230196270619245,-0.0885892275592377,0.00164771052350648,0.0590083976941555
CD300E,CMRF35-like molecule 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36013,0.0155004799658303,0.042319059438385,-0.0674448765334044,0.098445836465065,0.714169163272186
CD300E,CMRF35-like molecule 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36013,-0.0684045324185837,0.0254054987996801,-0.118199310065957,-0.0186097547712106,0.00710760266442761
CD300E,CMRF35-like molecule 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36013,-0.0354674380105994,0.0782857560125972,-0.18890751979529,0.117972643774091,0.650525296377293
CD300E,CMRF35-like molecule 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36013,-0.0271097533331184,0.0507533699721525,-0.126586358478537,0.0723668518123005,0.593255946889032
CD300E,CMRF35-like molecule 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36013,-0.0785684240038475,0.0575577826319156,-0.191381677962402,0.0342448299547071,0.172283277884223
CD300E,CMRF35-like molecule 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36013,0.0468966038691336,0.0609082214881128,-0.0724835102475675,0.166276717985835,0.44135098296819
CD300E,CMRF35-like molecule 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36013,-0.104013800080277,0.0714484805373572,-0.244052821933497,0.0360252217729433,0.145493738228516
CD300E,CMRF35-like molecule 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36013,-0.08773432304797,0.0497741858837497,-0.185291727380119,0.00982308128417934,0.0780012338123488
CD300E,CMRF35-like molecule 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36013,-0.0378936075515456,0.0216902228957211,-0.0804064444271589,0.00461922932406772,0.0806724457298123
CD300E,CMRF35-like molecule 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36013,-0.042533646909715,0.0349314136709708,-0.110999217704818,0.0259319238853877,0.223402171966606
CD300E,CMRF35-like molecule 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36013,-0.082289711527055,0.0566919225360603,-0.193405879697733,0.0288264566436231,0.146676196819285
CD300E,CMRF35-like molecule 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36013,-0.107281094132354,0.0690859993723142,-0.242689652902089,0.0281274646373822,0.120498550200581
CD300E,CMRF35-like molecule 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36013,-0.0534827680911564,0.0406781324305993,-0.133211907655131,0.0262463714728182,0.188624745404646
CD300E,CMRF35-like molecule 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36013,-0.0882872764377892,0.0631076169895107,-0.21197820573723,0.0354036528616518,0.161856150125909
CD300E,CMRF35-like molecule 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36013,-0.105194878402949,0.0631757638773209,-0.229019375602498,0.0186296187965998,0.0959321784316843
CD300E,CMRF35-like molecule 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36013,-0.0183181412756052,0.035099234850035,-0.0871126415816739,0.0504763590304634,0.601758514977581
CD300E,CMRF35-like molecule 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36013,-0.00958230293555759,0.0335754568040495,-0.0753901982714946,0.0562255924003794,0.775348702592679
CD300E,CMRF35-like molecule 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36013,-0.0793245957656469,0.0504249422378949,-0.178157482551921,0.0195082910206271,0.115733202577704
CD300E,CMRF35-like molecule 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35973,-0.0757942562021801,0.0681028496490625,-0.209275841514343,0.0576873291099825,0.265771307925255
CD300E,CMRF35-like molecule 2,Mental health,X29059.Recent inability to stop or control worrying,35979,0.0807145205252551,0.0717422477134177,-0.0599002849930436,0.221329326043554,0.260599106804832
CD300E,CMRF35-like molecule 2,Mental health,X29060.Recent worrying too much about different things,35978,0.0197299936799325,0.064246619497356,-0.106193380534885,0.14565336789475,0.758777623220493
CD300E,CMRF35-like molecule 2,Mental health,X29061.Recent trouble relaxing,35974,-0.0271613093466962,0.068586536796817,-0.161590921468457,0.107268302775065,0.692105294452557
CD300E,CMRF35-like molecule 2,Mental health,X29062.Recent restlessness,35982,0.141492012612071,0.092818236766093,-0.040431731449471,0.323415756673613,0.127451958248332
CD300E,CMRF35-like molecule 2,Mental health,X29063.Recent easy annoyance or irritability,35970,0.00286934642411963,0.0658915328451084,-0.126278057952293,0.132016750800532,0.965267068487984
CD300E,CMRF35-like molecule 2,Mental health,X29064.Recent feelings of foreboding,35973,0.0536952283243808,0.0815359245940015,-0.106115183879862,0.213505640528624,0.510207355731518
CD300E,CMRF35-like molecule 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36013,-0.0167718353202059,0.0272689925960101,-0.0702190608083857,0.0366753901679739,0.53853957674835
CD300E,CMRF35-like molecule 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36013,-0.0844176214777186,0.0414093476259552,-0.165579942824591,-0.00325530013084638,0.0415241066844748
CD300E,CMRF35-like molecule 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36013,-0.0502967650898238,0.05676857369835,-0.16156316953859,0.0609696393589422,0.375648081898242
CD300E,CMRF35-like molecule 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36013,0.0353742031221348,0.0562834789746379,-0.0749414156681556,0.145689821912425,0.529695384446582
CD300E,CMRF35-like molecule 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36013,-0.0226535193041574,0.0351192959638986,-0.0914873393933986,0.0461803007850839,0.518918114750406
CD300E,CMRF35-like molecule 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36013,0.0091183561270996,0.0442368785649467,-0.0775859258601959,0.0958226381143951,0.836698409920299
CD300E,CMRF35-like molecule 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36013,-0.0602413325039971,0.0421143669869824,-0.142785491798483,0.0223028267904883,0.152637980399691
CD300E,CMRF35-like molecule 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36013,0.000909067688583506,0.041963838692297,-0.0813400561483187,0.0831581915254857,0.982717265593555
CD300E,CMRF35-like molecule 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36013,0.0204162174420124,0.0526372724020616,-0.0827528364660284,0.123585271350053,0.698126208438184
CD300E,CMRF35-like molecule 2,Mental health,X29076.Felt loved as a child,35942,-0.0511027388919857,0.0549502003319007,-0.158805131542511,0.0565996537585397,0.352410599285674
CD300E,CMRF35-like molecule 2,Mental health,X29077.Physically abused by family as a child,35953,-0.00363738087509393,0.0710569871418763,-0.142909075673172,0.135634313922984,0.959175806161168
CD300E,CMRF35-like molecule 2,Mental health,X29078.Felt hated by family member as a child,35945,0.0276114083329917,0.080242529161728,-0.129663948823995,0.184886765489979,0.730781367930731
CD300E,CMRF35-like molecule 2,Mental health,X29079.Sexually molested as a child,35929,0.0540272566178608,0.117686395565077,-0.17663807868969,0.284692591925412,0.646191643342998
CD300E,CMRF35-like molecule 2,Mental health,X29080.Someone to take to doctor when needed as a child,35940,-0.118562014761527,0.0834828211456764,-0.282188344207053,0.0450643146839983,0.155592957305617
CD300E,CMRF35-like molecule 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35950,0.0852042755661123,0.121072775385034,-0.152098364188554,0.322506915320779,0.481614322842246
CD300E,CMRF35-like molecule 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35924,0.0973145668772205,0.102601104427419,-0.103783597800521,0.298412731554962,0.342919069786471
CD300E,CMRF35-like molecule 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35962,0.13264441790423,0.116309991834645,-0.0953231660916732,0.360612001900133,0.254140674181848
CD300E,CMRF35-like molecule 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35954,-0.103537585008544,0.356566595686835,-0.802408112554741,0.595332942537652,0.771538500320738
CD300E,CMRF35-like molecule 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35947,0.0032434493410898,0.222871433325056,-0.43358455997602,0.440071458658199,0.988389186136114
CD300E,CMRF35-like molecule 2,Mental health,X29086.Experienced a violent or sexual assault,35968,-0.0329738510974434,0.126939196443009,-0.28177467612574,0.215826973930853,0.795055403891404
CD300E,CMRF35-like molecule 2,Mental health,X29087.Experienced a life-threatening injury or illness,35959,0.216739796850944,0.0623200784035761,0.0945924431799351,0.338887150521954,0.00050837851471475
CD300E,CMRF35-like molecule 2,Mental health,X29088.Experienced a marital separation or divorce,35958,0.0374107266403681,0.0625401406556407,-0.0851679490446877,0.159989402325424,0.549733285140746
CD300E,CMRF35-like molecule 2,Mental health,X29089.Experienced the death of a spouse or partner,35969,0.0910422409977907,0.0938517648887836,-0.0929072181842252,0.274991700179807,0.332046314722478
CD300E,CMRF35-like molecule 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35961,0.111227840896807,0.0763072147924738,-0.0383343000964413,0.260789981890056,0.144984659464644
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35955,-0.403946862351526,0.050769997165287,-0.503456056795489,-0.304437667907564,2.03667545257377e-15
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35349,-0.294823644649919,0.0544947156053705,-0.401633287236445,-0.188014002063393,6.51426259133806e-08
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35369,-0.277493441924259,0.0544819065360543,-0.384277978734926,-0.170708905113593,3.6137562962267e-07
CD300E,CMRF35-like molecule 2,Mental health,X29104.Ever used cannabis,35949,-0.251412296466438,0.0684732775606139,-0.385619920485241,-0.117204672447635,0.000242667111259885
CD300E,CMRF35-like molecule 2,Mental health,X29108.Ever thought that life not worth living,35922,0.161705147346408,0.0682528318951151,0.0279295968319825,0.295480697860834,0.0178520263425002
CD300E,CMRF35-like molecule 2,Mental health,X29109.Ever contemplated self-harm,35929,0.13713243501205,0.0954183879342563,-0.0498876053390921,0.324152475363193,0.150712418470964
CD300E,CMRF35-like molecule 2,Mental health,X29111.Ever self-harmed,35941,-0.110125857987607,0.170126563040345,-0.443573921546684,0.223322205571469,0.517446886842325
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35942,0.101399502635765,0.103221481778702,-0.100914601650491,0.303713606922021,0.325960395956427
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36617,0.0134363933007428,0.0560721878229327,-0.0964650948322052,0.123337881433691,0.810625790506336
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36617,-0.00147681186275763,0.0427832427606236,-0.0853319676735798,0.0823783439480646,0.972464577627947
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36617,0.00303376011198667,0.0538274828080346,-0.102468106191761,0.108535626415734,0.955055787114234
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36617,0.0427064421421333,0.0886454354587263,-0.13103861135697,0.216451495641237,0.629984651885945
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35932,-0.107838648529753,0.0586850992623394,-0.222861443083939,0.00718414602443178,0.0661645536557132
CD300E,CMRF35-like molecule 2,Health and medical history,X29153.Pain or discomfort today,35946,0.162397063633607,0.0536588786369748,0.0572256615051361,0.267568465762077,0.00248283735893349
CD300E,CMRF35-like molecule 2,Mental health,X29154.Anxiety or depression today,35946,0.186717898738324,0.0709756371459602,0.0476056499322425,0.325830147544406,0.00853790459520331
CD300E,CMRF35-like molecule 2,Mental health,X29166.Frequency of confiding in someone close,35772,-0.143764209583455,0.0532372838482748,-0.248109285926074,-0.0394191332408362,0.00694100302500142
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35929,0.00915844653249808,0.0102827964167019,-0.0109958344442376,0.0293127275092338,0.373142345730937
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35929,-0.00333017802945296,0.0106384458039798,-0.0241815318052533,0.0175211757463474,0.754264967498145
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35929,-0.0220703060562318,0.0113032782886747,-0.0442247315020343,8.41193895707339e-05,0.0509100115665198
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35929,0.036610587358842,0.0156343110545384,0.00596733769194684,0.0672538370257372,0.0192236959050707
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35929,-0.0486249207341527,0.0312945420609752,-0.109962223173664,0.0127123817053587,0.12027941627757
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35929,-0.011525790528592,0.0114473105056929,-0.03396251911975,0.010910938062566,0.314037333864776
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35924,0.00872526999393829,0.0120545407760756,-0.0149016299271698,0.0323521699150464,0.469201796865121
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35924,-0.0156184087739312,0.0189330083098473,-0.0527271050612319,0.0214902875133696,0.409438132524257
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35924,0.00639997774409846,0.0217299154894788,-0.0361906566152801,0.048990612103477,0.768366010618267
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35924,0.0527563308520177,0.0263797957771695,0.00105193112876537,0.10446073057527,0.0455504772772671
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35924,-0.0631553192569804,0.0436205963906801,-0.148651688182713,0.0223410496687526,0.147706690993854
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35924,-0.0282679843039113,0.0175104818300781,-0.0625885286908644,0.00605256008304179,0.106495376015473
CD300E,CMRF35-like molecule 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35747,-0.261319717865344,0.0647513179744942,-0.388232301095353,-0.134407134635335,5.49976359247135e-05
CD300E,CMRF35-like molecule 2,Mental health,X29172.Freuency of feeling that lacks companionship,35882,0.169384903527424,0.0609973685997718,0.049830061071871,0.288939745982977,0.00550167502111817
CD300E,CMRF35-like molecule 2,Mental health,X29173.Frequency of feeling left out,35854,0.173866546152462,0.0635514999341952,0.0493056062814398,0.298427486023485,0.00623732022415716
CD300E,CMRF35-like molecule 2,Mental health,X29174.Frequency of feeling isolated from others,35887,0.134263999123876,0.0649033154285353,0.00705350088394699,0.261474497363806,0.0386115941603231
CD300E,CMRF35-like molecule 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35939,-0.0671982578205514,0.0525499385958299,-0.170196137468378,0.0357996218272752,0.201025397052131
CD300E,CMRF35-like molecule 2,Mental health,X29176.Ability to make it through stressful events,35939,0.103400528511341,0.0509106857651755,0.00361558441159654,0.203185472611085,0.0422891353097163
CD300E,CMRF35-like molecule 2,Mental health,X29177.Quick recovery from stressful events,35939,-0.0832394084513431,0.0524186245923212,-0.185979912652293,0.0195010957496064,0.112335333462184
CD300E,CMRF35-like molecule 2,Mental health,X29178.Hard to snap back when something bad happens,35939,0.102266123345358,0.051065503302636,0.00217773687219155,0.202354509818525,0.0452520369121881
CD300E,CMRF35-like molecule 2,Mental health,X29179.Comes through difficult times with little trouble,35939,-0.045437616908255,0.052136419735114,-0.147624999589078,0.0567497657725685,0.383502114323441
CD300E,CMRF35-like molecule 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35939,0.06152069516681,0.0512980694676923,-0.039023520989867,0.162064911323487,0.230458229036834
CD300E,CMRF35-like molecule 2,Mental health,X29181.General happiness,35899,0.07093067755754,0.0534302071062065,-0.0337925283706249,0.175653883485705,0.184372026734235
CD300E,CMRF35-like molecule 2,Mental health,X29182.Belief that own life is meaningful,35801,-0.113702364490723,0.0541425181202285,-0.21982170000637,-0.00758302897507472,0.0357585557935818
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34870,-0.0368105190011862,0.0491775690862779,-0.133198554410291,0.0595775164079185,0.454173114688609
CD300E,CMRF35-like molecule 2,Health and medical history,X2946.Father's age,33565,-0.0199742735080807,0.00950346288063632,-0.0386010607541279,-0.00134748626203353,0.0356220185346291
CD300E,CMRF35-like molecule 2,Health and medical history,X2966.Age high blood pressure diagnosed,35560,-0.0433294911023709,0.00822432897822055,-0.0594491758996832,-0.0272098063050586,1.41706065232011e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51736,0.0780844040162748,0.00320119040223794,0.0718100708278885,0.0843587372046612,8.98667385707611e-130
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51737,-0.0038758362250193,0.00348116608214475,-0.010698921746023,0.00294724929598442,0.265559844812926
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30020.Haemoglobin concentration,51737,-0.0355690829523928,0.00365664990265795,-0.0427361167616024,-0.0284020491431833,2.5467767755878e-22
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30030.Haematocrit percentage,51737,-0.021955600148826,0.0035929883825055,-0.0289978573785367,-0.0149133429191152,1.00792543007542e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30040.Mean corpuscular volume,51737,-0.0249805547573227,0.00320605274244856,-0.0312644181325219,-0.0186966913821235,6.88923306766468e-15
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51737,-0.0393801591741295,0.00321364403083719,-0.0456789014745704,-0.0330814168736887,2.04341437186221e-34
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51737,-0.0326142336022488,0.00312507986693269,-0.0387393901414369,-0.0264890770630608,1.92828282276871e-25
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51737,0.0635205794396696,0.00325534145974231,0.0571401101785747,0.0699010487007645,4.06357567251525e-84
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30080.Platelet count,51737,0.0191105426060776,0.00319973413120208,0.0128390637089215,0.0253820215032337,2.36997525497783e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30090.Platelet crit,51737,0.0312646807679298,0.00325436780099997,0.0248861198779698,0.0376432416578897,8.20445737306375e-22
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51737,0.0145437064716676,0.00302928797916331,0.00860630203250749,0.0204811109108277,1.58836554769888e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30110.Platelet distribution width,51737,0.00154631674469058,0.00311323590679509,-0.0045556256326278,0.00764825912200896,0.619411578281125
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30120.Lymphocyte count,51699,-0.0129889167570644,0.003147782503834,-0.019158570464579,-0.00681926304954975,3.69824577306538e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30130.Monocyte count,51699,0.127497401253493,0.00304055342893118,0.121537916532788,0.133456885974198,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30140.Neutrophill count,51699,0.0732935311587911,0.00316787525680204,0.0670844956554591,0.0795025666621231,4.26433827735646e-117
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30150.Eosinophill count,51699,0.0500649489354143,0.00303250648488557,0.0441212362250386,0.05600866164579,7.01000083720884e-61
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30160.Basophill count,51699,0.153915835194215,0.0291088987770609,0.0968623935911752,0.210969276797254,1.25067176498579e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30170.Nucleated red blood cell count,51699,-0.0137237533178179,0.144392580105754,-0.296733210325096,0.26928570368946,0.924280125375446
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30180.Lymphocyte percentage,51700,-0.0760082926717748,0.00307672030433419,-0.0820386644682698,-0.0699779208752798,5.11457889287678e-133
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30190.Monocyte percentage,51700,0.0843500515048264,0.00307088640931852,0.0783311141425621,0.0903689888670907,1.80540701864324e-163
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30200.Neutrophill percentage,51700,0.0328966606518336,0.00306436715322002,0.0268905010315224,0.0389028202721449,8.04642175876156e-27
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30210.Eosinophill percentage,51700,0.0250302556819327,0.00301717016840465,0.0191166021518596,0.0309439092120058,1.13554651250224e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30220.Basophill percentage,51700,0.00724271217481545,0.00315414931712812,0.00106057951324434,0.0134248448363866,0.0216705576052501
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51698,-0.00977183160550302,0.144654409197666,-0.293294473632928,0.273750810421922,0.946142097544376
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30240.Reticulocyte percentage,51349,0.0226416370280499,0.00333363040083663,0.0161077214424101,0.0291755526136897,1.13406002488825e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30250.Reticulocyte count,51349,0.0207809511708542,0.00336383115002438,0.0141878421168064,0.027374060224902,6.61189514723508e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30260.Mean reticulocyte volume,51349,0.0102953397162443,0.00315713469510212,0.00410735571384418,0.0164833237186445,0.0011119285338265
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30270.Mean sphered cell volume,51349,-0.0137001316572369,0.00317278392977064,-0.0199187881595874,-0.00748147515488647,1.58103897690895e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30280.Immature reticulocyte fraction,51349,0.034485235875325,0.00327728536822742,0.0280617565535993,0.0409087151970508,7.80116078962135e-26
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51349,0.0323613810558478,0.00337423561147718,0.0257478792573526,0.0389748828543431,9.6155638893351e-22
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30300.High light scatter reticulocyte count,51349,0.0306849723273646,0.00338821516299415,0.024044070607896,0.0373258740468331,1.45429447855765e-19
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30500.Microalbumin in urine,37075,0.0922913944333059,0.00536295638290879,0.0817799999228047,0.102802788943807,2.89597461010215e-65
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51783,0.026064263392064,0.00337748779701645,0.0194443873099118,0.0326841394742163,1.23837760475302e-14
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30520.Potassium in urine,51737,-0.0174126608975554,0.0031571044063913,-0.0236005855340824,-0.0112247362610285,3.51730043960985e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30530.Sodium in urine,51749,-0.0299832021714555,0.00326271051860313,-0.0363781147879177,-0.0235882895549934,4.26326641145154e-20
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30600.Albumin,49565,-0.0933822660070623,0.00328349545790527,-0.0998179171045566,-0.086946614909568,1.33136062522234e-174
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30610.Alkaline phosphatase,51304,0.0899261123941631,0.00324426594159453,0.0835673511486378,0.0962848736396884,2.45120046430565e-166
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30620.Alanine aminotransferase,51289,-0.0098551506983567,0.00356006417829276,-0.0168328764878105,-0.00287742490890288,0.00564037655457541
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30630.Apolipoprotein A,49503,-0.0785739023939057,0.00358213220849031,-0.0855948815225467,-0.0715529232652647,1.86399741526678e-105
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30640.Apolipoprotein B,51141,-0.0155893611549418,0.00308821576885715,-0.0216422640619018,-0.0095364582479818,4.49897455837895e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30650.Aspartate aminotransferase,51223,0.0183361127689661,0.00328299423362322,0.0119014440710646,0.0247707814668676,2.36140892547442e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30660.Direct bilirubin,49729,0.00204052871679749,0.00335165684315913,-0.00452871869579442,0.00860977612938939,0.542655641284655
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30670.Urea,51288,0.0734702124998974,0.00319280667441379,0.0672123114180463,0.0797281135817484,7.63798218851271e-116
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30680.Calcium,49556,-0.0224342333930243,0.00331623600932875,-0.0289340559713087,-0.01593441081474,1.36854232123579e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30690.Cholesterol,51307,-0.0347751558715125,0.00310401131082792,-0.0408590180407352,-0.0286912937022898,4.68232184359894e-29
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30700.Creatinine,51294,0.167517643710123,0.00387068043105899,0.159931110065247,0.175104177354998,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30710.C-reactive protein,51224,0.183805201979048,0.00321560899808232,0.177502608342806,0.190107795615289,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30720.Cystatin C,51312,0.294765911903317,0.0031611354612907,0.288570086399187,0.300961737407447,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30730.Gamma glutamyltransferase,51290,0.0219429168843977,0.00375472575098743,0.0145836544124624,0.0293021793563331,5.16341756835552e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30740.Glucose,49531,-0.0165014294719357,0.00315611079199865,-0.022687406624253,-0.0103154523196183,1.72620025664024e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51187,0.0189306379758989,0.00317826101694034,0.0127012463826959,0.025160029569102,2.61850481439868e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30760.HDL cholesterol,49543,-0.0870611236955,0.0036983505031673,-0.0943098906817079,-0.079812356709292,5.83380243610867e-121
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30770.IGF-1,51199,-0.0190929088547717,0.0032994828979535,-0.0255598953347606,-0.0126259223747829,7.27582160651458e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30780.LDL direct,51253,-0.0249509041088782,0.0031024178399207,-0.0310316430751228,-0.0188701651426336,9.23765170250867e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30790.Lipoprotein A,46715,0.00437496614142876,0.00341125474402276,-0.00231109315685586,0.0110610254397134,0.199680433897967
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30810.Phosphate,49503,0.0079631947440641,0.00323237259870089,0.00162774445061035,0.0142986450375178,0.013763876174152
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30830.SHBG,49411,0.00460777374355134,0.00429707327660887,-0.00381448987860205,0.0130300373657047,0.283595435046785
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30840.Total bilirubin,51207,-0.0177023479160974,0.00339683380996406,-0.0243601421836269,-0.0110445536485678,1.89040037353336e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30850.Testosterone,51075,-0.0344784276917238,0.00531200817936424,-0.0448899637232777,-0.0240668916601699,8.72450299530917e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30860.Total protein,49531,0.0070131716592459,0.00328845648817265,0.000567796942427503,0.0134585463760643,0.0329639291164791
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30870.Triglycerides,51278,0.031687852419446,0.00325821922987967,0.0253017427288819,0.0380739621100102,2.59515244405755e-22
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30880.Urate,51275,0.0888075003577018,0.00385933656445269,0.0812432006913745,0.0963718000240291,7.66653178469971e-116
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30890.Vitamin D,50613,-0.0155769159839862,0.0035179256625101,-0.022472050282506,-0.00868178168546642,9.56263351361004e-06
CD300E,CMRF35-like molecule 2,Physical measures,X3137.Number of measurements made,49979,-0.0169061841027238,0.0356953200343253,-0.0868690113700015,0.0530566431645538,0.635772417845763
CD300E,CMRF35-like molecule 2,Physical measures,X3143.Ankle spacing width,42066,0.00909500422819908,0.00567493091661107,-0.00202786036835861,0.0202178688247568,0.109032436437533
CD300E,CMRF35-like molecule 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42065,-0.00746186996769639,0.00412939583778193,-0.015555485809749,0.000631745874356206,0.0707826394853781
CD300E,CMRF35-like molecule 2,Physical measures,X3146.Speed of sound through heel,42066,-0.012640887757709,0.00398751612096383,-0.0204564193547982,-0.00482535616061993,0.00152719475487797
CD300E,CMRF35-like molecule 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42066,-0.0110230674019786,0.00402554265804132,-0.0189131310117396,-0.00313300379221762,0.00618424243555828
CD300E,CMRF35-like molecule 2,Physical measures,X3148.Heel bone mineral density (BMD),42046,-0.0111431640021985,0.00404648046508585,-0.0190742657137668,-0.00321206229063023,0.00589883852442936
CD300E,CMRF35-like molecule 2,Health and medical history,X3526.Mother's age at death,42854,-0.0130412828404506,0.00415493060985037,-0.0211849468357574,-0.00489761884514393,0.00170016991758438
CD300E,CMRF35-like molecule 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",33012,0.0044824899494375,0.00720590671718094,-0.00964108721623713,0.0186060671151121,0.533936054213272
CD300E,CMRF35-like molecule 2,Physical measures,X4100.Ankle spacing width (left),36245,0.0124322011986535,0.00752700209831139,-0.00232072291403683,0.0271851253113438,0.098640806858604
CD300E,CMRF35-like molecule 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36243,-0.0109021846710654,0.00542344050990453,-0.0215321280704783,-0.00027224127165253,0.0444453955401925
CD300E,CMRF35-like molecule 2,Physical measures,X4103.Speed of sound through heel (left),36245,-0.023986093050298,0.00518768501989919,-0.0341539556893004,-0.0138182304112956,3.83219325005642e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36245,-0.0202446994069626,0.00526132303803096,-0.0305568925615033,-0.00993250625242192,0.000120136447961355
CD300E,CMRF35-like molecule 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36234,-0.0197937296010963,0.00529205809680849,-0.0301661634708409,-0.00942129573135164,0.000185168327831231
CD300E,CMRF35-like molecule 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36245,-0.0202465646041695,0.0052616432500401,-0.0305593853742481,-0.00993374383409086,0.00012007759029206
CD300E,CMRF35-like molecule 2,Physical measures,X4119.Ankle spacing width (right),36235,0.0124516089023403,0.00734816008676492,-0.00195078486771892,0.0268540026723996,0.0902071756465162
CD300E,CMRF35-like molecule 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36234,-0.0156536560300514,0.00544273490930635,-0.0263214164522919,-0.00498589560781099,0.00403782378504226
CD300E,CMRF35-like molecule 2,Physical measures,X4122.Speed of sound through heel (right),36235,-0.0268872712736453,0.00515982507205512,-0.0370005284148734,-0.0167740141324173,1.928574131554e-07
CD300E,CMRF35-like molecule 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36235,-0.0234177675179694,0.00524993674534724,-0.03370764353885,-0.0131278914970888,8.29082799654587e-06
CD300E,CMRF35-like molecule 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36223,-0.0239225525508804,0.00527750250017386,-0.0342664574512212,-0.0135786476505396,5.90585673779729e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36235,-0.0234168946266399,0.00524993643478355,-0.0337067700388156,-0.0131270192144641,8.29723604878305e-06
CD300E,CMRF35-like molecule 2,Physical measures,X4194.Pulse rate,36622,0.0236873305286644,0.00491382356196011,0.0140562363472226,0.0333184247101062,1.45795434230531e-06
CD300E,CMRF35-like molecule 2,Physical measures,X4195.Pulse wave reflection index,36622,-0.0116673748509852,0.00515196642916654,-0.0217652290521516,-0.00156952064981878,0.023561043464494
CD300E,CMRF35-like molecule 2,Physical measures,X4196.Pulse wave peak to peak time,36614,-0.0113620893195652,0.00569556358817986,-0.0225253939523977,-0.000198784686732654,0.0460874123774391
CD300E,CMRF35-like molecule 2,Physical measures,X4198.Position of the pulse wave peak,36622,0.0148107651357656,0.00616090081910978,0.00273539953031045,0.0268861307412208,0.0162396005054493
CD300E,CMRF35-like molecule 2,Physical measures,X4199.Position of pulse wave notch,36622,0.017048402524064,0.0049892198541957,0.00726953160984043,0.0268272734382876,0.000636185487568577
CD300E,CMRF35-like molecule 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36622,0.0193663285933832,0.00627418999911601,0.00706891619511578,0.0316637409916506,0.00203105090250761
CD300E,CMRF35-like molecule 2,Physical measures,X4269.Number of triplets attempted (left),36396,0.228007707949107,0.146391134112454,-0.058918914911303,0.514934330809517,0.119386786139437
CD300E,CMRF35-like molecule 2,Physical measures,X4270.Volume level set by participant (left),36305,0.0174175994332808,0.0456923910702314,-0.0721394870643728,0.106974685930934,0.70307088519898
CD300E,CMRF35-like molecule 2,Physical measures,X4276.Number of triplets attempted (right),36399,0.226786526210967,0.14355009761032,-0.05457166510526,0.508144717527194,0.114183591238495
CD300E,CMRF35-like molecule 2,Physical measures,X4277.Volume level set by participant (right),36309,0.100762148509498,0.0454310824375506,0.011717226931899,0.189807070087097,0.0265898743768577
CD300E,CMRF35-like molecule 2,Cognitive function,X4288.Time to answer,36585,0.00160149015250963,0.00585513234269893,-0.00987456923918028,0.0130775495441995,0.784461335750591
CD300E,CMRF35-like molecule 2,Cognitive function,X4290.Duration screen displayed,36585,0.0187400021646294,0.00547546030368176,0.00800809996941312,0.0294719043598456,0.000623495014865997
CD300E,CMRF35-like molecule 2,Physical measures,X46.Hand grip strength (left),52337,-0.0598156170917156,0.00409727700171805,-0.0678462800150829,-0.0517849541683482,4.61454321938322e-48
CD300E,CMRF35-like molecule 2,Physical measures,X47.Hand grip strength (right),52337,-0.0602343225974575,0.00404859910511235,-0.0681695768434777,-0.0522990683514373,7.70487507906333e-50
CD300E,CMRF35-like molecule 2,Physical measures,X48.Waist circumference,52394,0.0957388029229175,0.00767393787083908,0.0806978846960729,0.110779721149762,1.30733240167201e-35
CD300E,CMRF35-like molecule 2,Health and medical history,X4803.Tinnitus,36437,0.0113728862080864,0.0515633298764134,-0.0896912403496839,0.112437012765857,0.825439616424893
CD300E,CMRF35-like molecule 2,Working and living environment,X4825.Noisy workplace,36518,0.0449717524082955,0.0494386102876584,-0.0519279237555151,0.141871428572106,0.363035663543384
CD300E,CMRF35-like molecule 2,Working and living environment,X4836.Loud music exposure frequency,36469,0.0182092595878801,0.068360634259546,-0.11577758356083,0.15219610273659,0.789960826540453
CD300E,CMRF35-like molecule 2,Physical measures,X49.Hip circumference,52389,0.0141053231439054,0.00568293270802373,0.00296677503617884,0.0252438712516319,0.0130697421731906
CD300E,CMRF35-like molecule 2,Physical measures,X50.Standing height,52347,0.0147460325224724,0.0043016599441824,0.00631477903187488,0.0231772860130699,0.000609106802354403
CD300E,CMRF35-like molecule 2,Health and medical history,X5057.Number of older siblings,35573,-0.00762564678181829,0.0489428194150881,-0.103553572835391,0.0883022792717544,0.87618945551462
CD300E,CMRF35-like molecule 2,Physical measures,X51.Seated height,52241,0.00153566726715577,0.00374416522981417,-0.00580289658327999,0.00887423111759154,0.68170004484088
CD300E,CMRF35-like molecule 2,Eye measures,X5181.Ever had eye surgery,33974,0.362990107389726,0.105819101973212,0.155584667522231,0.570395547257222,0.000607478308245923
CD300E,CMRF35-like molecule 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33962,0.0156250201038326,0.00634422995179425,0.0031903293983159,0.0280597108093494,0.0138141502228493
CD300E,CMRF35-like molecule 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33958,0.00979814244609853,0.00654145366325227,-0.00302310673387592,0.022619391626073,0.13423009814402
CD300E,CMRF35-like molecule 2,Eye measures,X5190.Duration at which refractometer first shown (right),33905,0.00708391772379522,0.00654046566953574,-0.00573539498849483,0.0199032304360853,0.27881737870333
CD300E,CMRF35-like molecule 2,Eye measures,X5193.Duration at which refractometer first shown (left),33901,0.0107232527222355,0.00656941244692244,-0.00215279567373247,0.0235993011182035,0.102675672970119
CD300E,CMRF35-like molecule 2,Eye measures,"X5199.logMAR, initial (right)",33940,-0.0292088983292668,0.0572647498705714,-0.141447808075587,0.0830300114170532,0.610025129229891
CD300E,CMRF35-like molecule 2,Eye measures,X5200.Final number of letters displayed (right),33940,-0.127577571597065,0.345364493346272,-0.804491978555759,0.549336835361629,0.711844406267945
CD300E,CMRF35-like molecule 2,Eye measures,"X5201.logMAR, final (right)",33881,0.00549176600334752,0.00628801836457169,-0.00683274999121298,0.017816281997908,0.382501199553194
CD300E,CMRF35-like molecule 2,Eye measures,X5202.Number of rounds to result (right),33940,-0.0928308685753358,0.0541895270622309,-0.199042341617308,0.0133806044666368,0.0867564177022793
CD300E,CMRF35-like molecule 2,Eye measures,"X5206.logMAR, initial (left)",33935,0.0451854211600467,0.0574554095095704,-0.0674271814787114,0.157798023798805,0.431642768533879
CD300E,CMRF35-like molecule 2,Eye measures,X5207.Final number of letters displayed (left),33935,0.0112663431910541,0.340251352336591,-0.655626307388665,0.678158993770773,0.973586652173947
CD300E,CMRF35-like molecule 2,Eye measures,"X5208.logMAR, final (left)",33889,0.00355923133082324,0.00632938367008862,-0.00884636066255045,0.0159648233241969,0.573911911202541
CD300E,CMRF35-like molecule 2,Eye measures,X5209.Number of rounds to result (left),33931,0.0153308603683894,0.0544068991390651,-0.0913066619441782,0.121968382680957,0.77812197892608
CD300E,CMRF35-like molecule 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33735,-0.0261596223307151,0.00625454603521512,-0.0384185325597367,-0.0139007121016935,2.93130581507471e-05
CD300E,CMRF35-like molecule 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33735,-0.0280874741850277,0.00613591456964563,-0.0401138667415331,-0.0160610816285223,4.81546097688001e-06
CD300E,CMRF35-like molecule 2,Eye measures,X5256.Corneal hysteresis (right),33735,0.00308152095590052,0.00638083754081468,-0.00942492062409626,0.0155879625358973,0.629163459071625
CD300E,CMRF35-like molecule 2,Eye measures,X5257.Corneal resistance factor (right),33735,-0.0139299458623651,0.00628511767076691,-0.0262487764970683,-0.00161111522766197,0.0267120215993874
CD300E,CMRF35-like molecule 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33706,-0.0253765635319556,0.00630310153841394,-0.037730642547247,-0.0130224845166643,5.75451964262434e-05
CD300E,CMRF35-like molecule 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33706,-0.0275667319795221,0.00622625856506488,-0.0397701987670493,-0.015363265191995,9.73224394563528e-06
CD300E,CMRF35-like molecule 2,Eye measures,X5264.Corneal hysteresis (left),33706,0.00504731702485883,0.00631741509476579,-0.00733481656088212,0.0174294506105998,0.424354892538625
CD300E,CMRF35-like molecule 2,Eye measures,X5265.Corneal resistance factor (left),33706,-0.0119797406190925,0.00626829348875279,-0.0242655958570479,0.000306114618863002,0.0560393649271138
CD300E,CMRF35-like molecule 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34644,0.291084749082854,0.261831559638826,-0.222105107809246,0.804274605974954,0.266300538159947
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52324,0.0592764100521367,0.0167700915603605,0.0264070305938301,0.0921457895104433,0.000409092120215492
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52324,0.035605600125999,0.0195728873537556,-0.00275725908736195,0.0739684593393599,0.0689044051150032
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52324,0.0465118175582663,0.0477810380398935,-0.047139016999925,0.140162652116458,0.330346214890764
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52324,-0.0195050153015001,0.00766037154880374,-0.0345193435371554,-0.00449068706584471,0.0108958202530921
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52324,0.00100144152076449,0.00710378666271144,-0.0129219803381499,0.0149248633796789,0.887892535404613
CD300E,CMRF35-like molecule 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38995,-0.0298751527185771,0.0094650842453458,-0.0484267178394548,-0.0113235875976993,0.00160211269357927
CD300E,CMRF35-like molecule 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38995,-0.0514848797222939,0.0295232473681721,-0.109350444563911,0.00638068511932334,0.0812102909906517
CD300E,CMRF35-like molecule 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38995,-0.0162677787836416,0.0182605967786612,-0.0520585484698176,0.0195229909025344,0.373020682734188
CD300E,CMRF35-like molecule 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38995,-0.00253789110215787,0.0110077943515798,-0.0241131680312543,0.0190373858269386,0.817665838657451
CD300E,CMRF35-like molecule 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52398,0.0321151712176317,0.0162690140766368,0.000227903627423559,0.0640024388078399,0.0483923286735138
CD300E,CMRF35-like molecule 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52398,0.0321151712176317,0.0162690140766368,0.000227903627423559,0.0640024388078399,0.0483923286735138
CD300E,CMRF35-like molecule 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52398,-0.0137919173292181,0.0118185712571563,-0.0369563169932445,0.00937248233480822,0.243234204294781
CD300E,CMRF35-like molecule 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52398,-0.0276272818978814,0.0208189211971964,-0.0684323674443862,0.0131778036486235,0.184512302541188
CD300E,CMRF35-like molecule 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52398,0.00332895219552492,0.0489088832828815,-0.0925324590389227,0.0991903634299726,0.9457349671516
CD300E,CMRF35-like molecule 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52398,0.0570885377263323,0.0345795669253118,-0.0106874134472788,0.124864488899943,0.0987655131822272
CD300E,CMRF35-like molecule 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52398,0.053640607693216,0.0522124146039994,-0.0486957249306228,0.155976940317055,0.304264473350201
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52323,0.0025799282723027,0.0104845908646199,-0.0179698698223523,0.0231297263669577,0.805631282162932
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52323,0.0700462009252964,0.0185680710485608,0.0336527816701173,0.106439620180476,0.000162077254871407
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52323,0.000908947449137461,0.00958274944810113,-0.0178732414691408,0.0196911363674157,0.924432811233012
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52323,0.0416815539550966,0.01417450039233,0.0138995331861299,0.0694635747240634,0.00327892088035624
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52323,0.0287588614971135,0.01436029679375,0.000612679781363527,0.0569050432128635,0.0452246334175711
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52323,0.0764881790860243,0.00806707860072662,0.0606767050286001,0.0922996531434485,2.73336137295328e-21
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37181,0.0586870433110042,0.0166372645023035,0.0260780048864893,0.091296081735519,0.000421783413268302
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37181,0.0136416444124264,0.0158586509472038,-0.0174413114440932,0.0447246002689459,0.389701694427597
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37181,0.109291574638115,0.0229048408441214,0.0643980865836375,0.154185062692593,1.85833288217667e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37181,0.0226153598263155,0.0171971597728988,-0.0110910733285662,0.0563217929811973,0.18852364995709
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52271,0.0325779133035204,0.0284320658570883,-0.0231489357763728,0.0883047623834136,0.251882915727516
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52271,0.00996654129319716,0.0354315686480357,-0.0594793332569527,0.079412415843347,0.778490539035409
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52271,0.25954690524932,0.0721686158148217,0.118096418252269,0.40099739224637,0.000323313370947219
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52271,0.0664248599183567,0.0681189690968029,-0.0670883195113769,0.19993803934809,0.329505674263248
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52271,-0.0207223593787202,0.0268713792852892,-0.073390262777887,0.0319455440204467,0.440614801559294
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52271,0.0389451244453584,0.0314861597702328,-0.0227677487042978,0.100657997595015,0.216137737866523
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52271,0.0176450463225062,0.0133269021109337,-0.00847568181492375,0.0437657744599362,0.1855101496284
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35709,0.145922986215026,0.0230144548803547,0.100814654649531,0.191031317780522,2.4305110013097e-10
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35709,0.145897321708354,0.0226292858790317,0.101543921385452,0.190250722031257,1.21331012020019e-10
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35709,0.1861242617969,0.0320412660644589,0.123323380310561,0.248925143283239,6.56017387617961e-09
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35709,0.00640969884505533,0.0115905602929283,-0.0163077993290841,0.0291271970191948,0.580273768479332
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38865,-0.00697056488095423,0.0102801152205333,-0.0271195907131994,0.0131784609512909,0.497747087535114
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38865,-0.0455894629611382,0.0113724588649324,-0.0678794823364058,-0.0232994435858706,6.1470088146247e-05
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38865,0.0159427712130766,0.0100760645329758,-0.00380631527155596,0.0356918576977091,0.113625172768467
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38866,0.0679790332263122,0.0234932131619764,0.0219323354288384,0.114025731023786,0.0038170241481773
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38866,0.061467596200161,0.0139574048376919,0.0341110827182849,0.0888241096820371,1.07377988476101e-05
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38866,0.123698582443583,0.0253868608559692,0.0739403351658836,0.173456829721283,1.11817998557285e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52323,-0.0411756067499336,0.0207775424653113,-0.0818995899819437,-0.000451623517923473,0.047520303608398
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52323,0.030896072609611,0.0167805746884993,-0.00199385377984763,0.0637859989990697,0.0656075402652493
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52323,0.0720382493310948,0.0331454372053107,0.00707319240868588,0.137003306253504,0.0297601829326204
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52323,0.00872310134957266,0.0187454474869578,-0.0280179757248647,0.04546417842401,0.641688644105423
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52323,-0.0106731768993393,0.0191600716952855,-0.0482269174220988,0.0268805636234202,0.57749642069907
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52323,0.140675090661431,0.0230613345899241,0.09547487486518,0.185875306457682,1.07681571888007e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52323,0.00787425590400909,0.00671639385148848,-0.00528987604490832,0.0210383878529265,0.241050916122922
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34220,0.0997007109599962,0.0172547667631639,0.065881368104195,0.133520053815797,7.95807153194424e-09
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34220,0.109529126361659,0.0207074599793726,0.0689425048020882,0.150115747921229,1.27393939554303e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34220,-0.0932718531779017,0.0154045006066652,-0.123464674366965,-0.0630790319888379,1.49654965365845e-09
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34220,0.00326667773965084,0.0137193215187673,-0.023623192437133,0.0301565479164347,0.811806150135132
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52433,0.0281760595647969,0.00816351575959423,0.0121755686759922,0.0441765504536015,0.000558525921170817
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52433,0.0832880297260199,0.0270607581114445,0.0302489438275886,0.136327115624451,0.00208760401607557
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52433,0.00998229306162773,0.00718602114258083,-0.0041023083778307,0.0240668945010862,0.164807237581977
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52433,0.00499588574324451,0.00671223385199527,-0.00816009260666622,0.0181518640931552,0.456705034998021
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52433,0.0691866350543778,0.011361174858746,0.0469187323312356,0.0914545377775199,1.1482194700106e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52433,0.0429371485623537,0.010256580980656,0.0228342498402679,0.0630400472844395,2.84552690135748e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52433,0.0143219178869145,0.0072457292754995,0.000120288506935502,0.0285235472668936,0.0480982248772693
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52433,0.120721191059523,0.0234907153815186,0.0746793889117465,0.166762993207299,2.78231475352405e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45200,-0.0385459513140363,0.00738435022470902,-0.0530192777544659,-0.0240726248736066,1.8112635498399e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45200,0.00109277306132754,0.0072654257122604,-0.0131474613347028,0.0153330074573579,0.880445110019934
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45200,0.0271031575928116,0.00941551949861569,0.00864873937552488,0.0455575758100984,0.00400002667363106
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45201,-0.0309827166501693,0.0146408619556801,-0.0596788060833023,-0.00228662721703625,0.0343442436399488
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45201,0.000134165118335757,0.00830864864814743,-0.0161507862320332,0.0164191164687047,0.987116796378954
CD300E,CMRF35-like molecule 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52205,-0.0277700366224529,0.00768203014847847,-0.0428268157134707,-0.0127132575314351,0.000301048432122415
CD300E,CMRF35-like molecule 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52205,-0.0289965756258854,0.00603513284530696,-0.0408254360026871,-0.0171677152490838,1.55990457786213e-06
CD300E,CMRF35-like molecule 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52205,0.0254573510352177,0.00681506128077558,0.0120998309248976,0.0388148711455379,0.000187817369770225
CD300E,CMRF35-like molecule 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52205,-0.0510335649397594,0.0104108701383712,-0.071438870410967,-0.0306282594685518,9.55194680204113e-07
CD300E,CMRF35-like molecule 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52228,-0.0580605405497998,0.0064946820391159,-0.070790117346467,-0.0453309637531327,4.1813017073546e-19
CD300E,CMRF35-like molecule 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52228,-0.0364772328879247,0.00907826940183796,-0.0542706409155271,-0.0186838248603223,5.88553808403036e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52323,-0.0586105579581255,0.00664994006555799,-0.0716444404866191,-0.0455766754296318,1.29226956438607e-18
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52323,-0.0534173882838981,0.00835696328198755,-0.0697970363165937,-0.0370377402512025,1.66816177911174e-10
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52323,0.0373329244952916,0.0178185994753247,0.00240846952365516,0.0722573794669281,0.0361668103167353
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52323,-0.0550305492165718,0.0163434266756163,-0.0870636655007797,-0.0229974329323639,0.000760737090831286
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52323,0.0565829432628675,0.0197361555800814,0.017900078325908,0.0952658081998271,0.00414788632565828
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52323,-0.0576306798030824,0.0203210646671011,-0.0974599665506005,-0.0178013930555643,0.00457201225198545
CD300E,CMRF35-like molecule 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42066,-0.0110210293808722,0.00402555536085162,-0.0189111178881414,-0.00313094087360308,0.0061939272900944
CD300E,CMRF35-like molecule 2,Physical activities,X864.Number of days or week walked 10+ minutes,51958,-0.151909650518748,0.0263725184820402,-0.203599786743547,-0.10021951429395,8.50944631601595e-09
CD300E,CMRF35-like molecule 2,Physical activities,X874.Duration of walks,49287,-0.00670654443347527,0.00308650213046829,-0.0127560886091931,-0.000657000257757417,0.0298019861584561
CD300E,CMRF35-like molecule 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51358,-0.214678153707785,0.0255707455055879,-0.264796814898737,-0.164559492516833,4.90812245616955e-17
CD300E,CMRF35-like molecule 2,Physical activities,X894.Duration of moderate activity,46522,-0.00957815103048707,0.0310160109652897,-0.0703695325224549,0.0512132304614808,0.757467280142671
CD300E,CMRF35-like molecule 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33342,-0.0307704973982114,0.00659330839531807,-0.0436933818530348,-0.017847612943388,3.14161738008616e-06
CD300E,CMRF35-like molecule 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51277,-0.285397090108861,0.0262533587324508,-0.336853673224464,-0.233940506993257,1.85462132916396e-27
CD300E,CMRF35-like molecule 2,Physical activities,X914.Duration of vigorous activity,42164,-0.000905214414662433,0.00357417086365376,-0.00791058930742381,0.00610016047809894,0.800066839743181
